

<!DOCTYPE html>

<html lang="uz-Cyrl-UZ">
<head>
   <!-- Global site tag (gtag.js) - Google Analytics -->
   <script async src="https://www.googletagmanager.com/gtag/js?id=UA-2682682-1"></script>
   <script>
      window.dataLayer = window.dataLayer || [];
      function gtag() { dataLayer.push(arguments); }
      gtag('js', new Date());
      gtag('config', 'UA-2682682-1');
   </script>
<title>

</title><meta charset="UTF-8" /><meta http-equiv="content-type" content="text/html; charset=UTF-8" /><meta name="viewport" content="width=device-width, initial-scale=1.0, minimum-scale=0.3, maximum-scale=3.0" /><link href="/css/mactform.css" rel="stylesheet" type="text/css" />

    <style type="text/css">
        /*.contents-caption DIV {
            float: right;
        }*/

        /*.mobilnav TD {
            height: 32px;
        }*/

        /*.mobilnav {
            border: 0px;
            padding: 0;
            background: url('/image/h-menu.gif') repeat-x scroll left top transparent;
        }*/

        body {
            margin: 0;
        }

        td {
            min-height: 22px;
        }

        /*#userComments {
            position: fixed;
            top: 0;
            left: 200px;
            width: 279px;
            height: 18px;
            background-color: Black;
            color: White;
            z-index: 2000;
            padding: 3px;
            display: none;
        }*/

        /*#fancybox_div {
            display: none;
        }*/

        /*#divContextRasporka {
            width: 270px;
        }*/

        /*#tddivContext {
            background-color: White;
        }*/

        /*#backButton {
            color: White;
            font-weight: bold;
            text-decoration: none;
        }*/

        /*#divCont {
            padding-top: 35px;
        }*/

        /*.main_menu ul .checkboxArea, .main_menu ul .checkboxAreaChecked {
            padding-top: 12px;
        }*/

        /*#item3 > ul > li {
            white-space: nowrap;
        }*/

        /*header > nav > ul > li > a {
            font-family: Arial;
            font-size: 11px;
        }*/

        /*#actContent a {
            font-size: 14px;
            font-family: Arial;
        }*/

        /*#selected_div {
            height: 250px;
            overflow: auto;
            padding: 6px 1px 1px 9px;
        }*/

        /*.enter_submit {
            background: url("/images/bg/search_button_bg.jpg") repeat-x scroll 0 0 transparent;
            border: 1px solid #7190EE;
            border-radius: 6px 6px 6px 6px;
            float: right;
            margin-right: 2px;
            cursor: pointer;
        }*/

        /*.enter_submit > div {
                background: url("/images/arrow/button_uzor4_left.png") no-repeat scroll 4px 7px transparent;
                float: left;
                width: 100%;
                cursor: pointer;
            }*/

        /*.enter_submit input[type="button"] {
                background: url("/images/arrow/button_uzor4_right.png") no-repeat scroll right 7px transparent;
                border: medium none;
                border-radius: 6px 6px 6px 6px;
                color: #FFFFFF;
                float: left;
                font-size: 12px;
                font-weight: bold;
                height: 21px;
                margin-left: 22px;
                margin-right: 4px;
                padding: 0 22px 3px 0;
                cursor: pointer;
            }*/

        .show_context {
            background-color: #FFFF00;
            color: inherit;
        }
    </style>
    <style id="tree_style" type="text/css">
        #divAct a, #divAct DIV, #divAct font, div#theDefCssID table td, th {
            font-size: 12pt;
        }
    </style>

    <script type="text/javascript" charset="utf-8">
        //window.onbeforeunload = function () {
        //    //document.getElementById("main_container").innerHTML = "";
        //    //window.body.style.background = "red";  //css("background", "red");
        //    //window.scrollTo(0, 0);
        //}

        window.onload = function () {
            setTimeout(function () { scrolPage(); }, 100);
        }

        function scrolPage() {
            var hash = location.hash.toString();
            if (hash.length > 2) {
                var elem = document.getElementById(location.hash.toString().substring(1));
                if (elem === null || elem === undefined) {
                    document.body.scrollTop = document.documentElement.scrollTop = 0;
                }
                else {
                    document.body.scrollTop = document.documentElement.scrollTop = elem.offsetTop - 10;
                }
            }
            else {
                document.body.scrollTop = document.documentElement.scrollTop = 0;
            }
        }
    </script>
</head>
<body>
    
    <a href="#DynContent" id="DynContentBtn"></a>
    <div style="display: none;">
        <div id="DynContent" style="width: 350px;">
            <table>
                <tr>
                    <td><span id="dynText"></span></td>
                </tr>
            </table>
        </div>
    </div>
    <div id="headcont">
        
        <header style="z-index: 2000;" id="headermenu">
            <div class='logo' style="padding: 0px 0px 0px 8px">
                <a href='/'><span></span></a>
            </div>
        </header>
        
    </div>
    <div id='main_container'>
        
        <section class='main_text'>
            <table style="width: 100%; font-family: Arial; font-size: 14px; font-weight: bold;">
                <tr>
                    <td style="width: 50%">
                        
                            <div class="act_warning">
                                Hujjat kuchini yo‘qotgan " " 26.02.2026
                            </div>
                        
                        
                        
                    </td>
                    <td style="width: 50%; text-align: right">
                        
                            <div class="act_warning">
                                <b>Hujjat 04.09.2024 00 sanasi holatiga</b>
                                <br />
                                <a style="color: green" href="/acts/-3594817">
                                    Amaldagi versiyaga o‘tish</a>
                            </div>
                        
                        
                    </td>
                </tr>
            </table>
            <div id="divAct" style="margin: 0px; padding: 0px 5px 0px 5px; background: white;">
                
                <div id="divCont" style="background:#ffffff;border:none;margin:auto;"><div class="INDEXES_ON_REF" style="display:none"><label id="s5987"></label><a id="onLBC-3594817">[<b>OKOZ:</b><div id="LBC6903"><span class="iorRN">1.</span><span class="iorVal">09.00.00.00 Tadbirkorlik va xoʻjalik faoliyati / 09.10.00.00 Sanoat / 09.10.23.00 Tibbiy sanoat. Mikrobiologiya sanoati. Farmatsevtika;</span></div><div id="LBC7382"><span class="iorRN">2.</span><span class="iorVal">14.00.00.00 Sogʻliqni saqlash. Jismoniy tarbiya. Sport. Turizm / 14.01.00.00 Sogʻliqni saqlash / 14.01.04.00 Sogʻliqni saqlash muassasalarini, aholini medikamentlar, dori-darmon vositalari va tibbiy buyumlar bilan taʼminlash. Dorixona]</span></div></a></div><div class="INDEXES_ON_REF" style="display:none"><label id="s5988"></label><a id="onLS-3594817">[<b>TSZ:</b><div id="LS3700"><span class="iorRN">1.</span><span class="iorVal">Ijtimoiy-madaniy masalalar / Sogʻliqni saqlash. Sanitariyaga oid qonun hujjatlari]</span></div></a></div><div class="ACCEPTING_BODY"><a id="-3595992">Oʻzbekiston Respublikasi Vazirlar Mahkamasining</a></div><div class="ACT_FORM"><a id="-3595993">qarori</a></div><div class="ACT_TITLE"><a id="-3595994">Dori vositalari, tibbiy buyumlar va tibbiy texnikani davlat roʻyxatidan oʻtkazish hamda roʻyxatdan oʻtkazilganlik guvohnomasi berish tartibi toʻgʻrisidagi nizomni tasdiqlash haqida</a></div><div class="BY_DEFAULT"><a id="-3595996"></a></div><div class="COMMENT"><label id="s527"></label><div class="COMMENTLEXUZ"><img src="/image/favicon.gif"> LexUZ sharhi</img></div></div><div class="COMMENT"><label id="s527"></label><a id="-7868292">Mazkur qaror Oʻzbekistan Respublikasi Vazirlar Mahkamasining 2025-yil 24-noyabrdagi 738-sonli “Dori vositalarini davlat roʻyxatidan oʻtkazish tartibi toʻgʻrisidagi hamda Tibbiy jihozlarni davlat roʻyxatidan oʻtkazish tartibi toʻgʻrisidagi nizomlarni tasdiqlash haqida”gi <a href="/acts/-7853907?ONDATE=26.02.2026 00#-7861132">qaroriga </a>asosan 2026-yil 26-fevraldan oʻz kuchini yoʻqotadi.</a></div><div class="ACT_TEXT"><a id="-3596043">Oʻzbekiston Respublikasining “Dori vositalari va farmatsevtika faoliyati toʻgʻrisida”gi<a href="/acts/-2856464"> Qonuniga </a>muvofiq hamda Oʻzbekiston Respublikasi Prezidentining “<a href="/acts/-3470869">Sogʻliqni saqlash idoralari faoliyatini yanada takomillashtirish toʻgʻrisida</a>” 2017-yil 12-iyundagi PQ-3052-son, “<a href="/acts/-3518939">Dori vositalari va tibbiyot buyumlari ishlab chiqarish hamda olib kirishni yanada tartibga solish chora-tadbirlari toʻgʻrisida</a>” 2018-yil 23-yanvardagi PQ-3489-son va “<a href="/acts/-3557212">Farmatsevtika tarmogʻini jadal rivojlantirish boʻyicha qoʻshimcha chora-tadbirlar toʻgʻrisida</a>” 2018-yil 14-fevraldagi PQ-3532-son qarorlari ijrosini taʼminlash maqsadida Vazirlar Mahkamasi qaror qiladi:</a></div><div class="ACT_TEXT"><a id="-3596044">1. Dori vositalari, tibbiy buyumlar va tibbiy texnikani davlat roʻyxatidan oʻtkazish hamda roʻyxatdan oʻtkazilganlik guvohnomasi berish tartibi toʻgʻrisidagi nizom <a href="/acts/-3594817#-3596052">ilovaga</a> muvofiq tasdiqlansin.</a></div><div class="ACT_TEXT"><a id="-3596045">2. Vazirliklar va idoralar bir oy muddatda oʻzlari qabul qilgan normativ-huquqiy hujjatlarni ushbu qarorga muvofiqlashtirsinlar.</a></div><div class="ACT_TEXT"><a id="-3596046">3. Vazirlar Mahkamasining “Dori vositalari va tibbiy buyumlarni roʻyxatdan oʻtkazish hamda roʻyxatdan oʻtkazilganlik guvohnomasi berish tartibi toʻgʻrisidagi nizomni tasdiqlash haqida” 2014-yil 22-dekabrdagi 352-son <a href="/acts/-2526157">qarori</a> (Oʻzbekiston Respublikasi QT, 2014-y., 12-son, 126-modda) oʻz kuchini yoʻqotgan deb hisoblansin.</a></div><div class="ACT_TEXT"><a id="-3596047">4. Mazkur qarorning bajarilishini nazorat qilish Oʻzbekiston Respublikasi Bosh vazirining oʻrinbosari Q.B. Akmalov va Sogʻliqni saqlash vaziri A.K. Shadmanov zimmasiga yuklansin.</a></div><div class="SIGNATURE"><a id="-3596048">Oʻzbekiston Respublikasining Bosh vaziri A. ARIPOV</a></div><div class="ACT_ESSENTIAL_ELEMENTS"><a id="-3596049">Toshkent sh.,</a></div><div class="ACT_ESSENTIAL_ELEMENTS"><a id="-3596050">2018-yil 23-mart,</a></div><div class="ACT_ESSENTIAL_ELEMENTS_NUM"><a id="-3596051">213-son</a></div><div class="BY_DEFAULT"><a id="-3596052"></a></div><div class="APPL_BANNER_LANDSCAPE_TITLE"><a id="-3596056">Vazirlar Mahkamasining 2018-yil 23-martdagi 213-son<a href="/acts/-3594817"> qaroriga <br /></a>ILOVA </a></div><div class="ACT_TITLE_APPL"><a id="-3596059">Dori vositalari, tibbiy buyumlar va tibbiy texnikani davlat roʻyxatidan oʻtkazish hamda roʻyxatdan oʻtkazilganlik guvohnomasi berish tartibi toʻgʻrisida</a></div><div class="ACT_FORM"><a id="-3596060"><strong>NIZOM</strong></a></div><div class="BY_DEFAULT"><a id="-3596061"></a></div><div class="TEXT_HEADER_DEFAULT"><a id="-3596062">1-bob. Umumiy qoidalar</a></div><div class="ACT_TEXT"><a id="-3596063">1. Ushbu Nizom dori vositalari, tibbiy buyumlar va tibbiy texnikani davlat roʻyxatidan oʻtkazish (keyingi oʻrinlarda roʻyxatdan oʻtkazish deb ataladi) hamda roʻyxatdan oʻtkazilganlik guvohnomasini (keyingi oʻrinlarda guvohnoma deb ataladi) berish tartibini belgilaydi.</a></div><div class="ACT_TEXT"><a id="-3596064">2. Ushbu Nizomda quyidagi asosiy tushunchalar va atamalar qoʻllaniladi:</a></div><div class="ACT_TEXT"><a id="-3596065"><strong>dori vositalari</strong> — kasalliklar profilaktikasi, ularga tashxis qoʻyish va ularni davolash, shuningdek odam organizmining holati va funksiyalarini oʻzgartirish uchun tibbiyot amaliyotida qoʻllanilishiga ruxsat etilgan dori moddalari (substansiyalar) va yordamchi moddalar asosida olingan vositalar, dori moddalari (substansiyalar), dori preparatlari;</a></div><div class="ACT_TEXT"><a id="-3596066"><strong>dori moddalari (substansiyalar)</strong> — farmakologik, immunologik yoki metabolik faollikka ega boʻlgan yoxud tashxis qoʻyish maqsadi uchun foydalaniladigan, tibbiyot amaliyotida qoʻllanilishiga ruxsat etilgan, kelib chiqishi tabiiy yoki sintetik moddalar;</a></div><div class="ACT_TEXT"><a id="-3596067"><strong>tibbiy buyumlar</strong> — kasalliklar profilaktikasi, ularga tashxis qoʻyish va ularni davolash uchun, shuningdek, odam organizmining holati va funksiyalarini oʻzgartirish uchun tibbiyot amaliyotida qoʻllanilishiga ruxsat etilgan buyumlar; </a></div><div class="ACT_TEXT"><a id="-3596068"><strong>tibbiy texnika</strong> — kasalliklar profilaktikasi, ularga tashxis qoʻyish va ularni davolash uchun, shuningdek, odam organizmining holati va funksiyalarini aniqlash hamda oʻzgartirish uchun tibbiyot amaliyotida qoʻllanilishiga ruxsat etilgan apparatlar, uskunalar, priborlar, asboblar, qurilmalar va majmualar;</a></div><div class="ACT_TEXT"><a id="-3596069"><strong>farmakologik vositalar</strong> — muayyan dori shakliga, klinikagacha tadqiqotlarda aniqlangan farmakologik faollikka va xavfsizlikka ega boʻlgan, klinik tadqiqot obyektlari boʻlgan modda yoki moddalar aralashmasi;</a></div><div class="ACT_TEXT" style="color:#808080;"><a id="-3596070"><strong>Oʻzbekiston Respublikasi Sogʻliqni saqlash vazirligi huzuridagi Farmatsevtika tarmogʻini rivojlantirish agentligining Dori vositalari, tibbiy buyumlar va tibbiy texnika ekspertizasi va standartlashtirish davlat markazi</strong> (keyingi oʻrinlarda Davlat markazi deb ataladi) — Farmatsevtika tarmogʻini rivojlantirish agentligining dori vositalari, tibbiy buyumlar va tibbiy texnikani davlat roʻyxatidan oʻtkazish, sifat nazorati, standartlashtirish va sertifikatlashtirishni amalga oshiradigan ishchi organi;</a></div><div class="COMMENT"><label id="s3935"></label><a id="edi-3596070"><a href="/acts/-3594817?ONDATE=15.02.2025 00#edi-7403902">Keyingi</a> tahrirga qarang.</a></div><div class="ACT_TEXT" style="color:#808080;"><a id="-3596071"><strong>ariza beruvchi</strong> — Davlat markaziga dori vositalari, tibbiy buyumlar va tibbiy texnikani davlat roʻyxatdan oʻtkazish va guvohnoma olish uchun murojaat qiluvchi tadbirkorlik subyekti, yuridik shaxs (yoki uning nomidan harakat qiluvchi ishonchli vakil);</a></div><div class="COMMENT"><label id="s3935"></label><a id="edi-3596071"><a href="/acts/-3594817?ONDATE=15.02.2025 00#edi-7403913">Keyingi</a> tahrirga qarang.</a></div><div class="ACT_TEXT" style="color:#808080;"><a id="-3596072"><strong>roʻyxatdan oʻtkazish hujjatlari</strong> — dori vositalari, tibbiy buyumlar va tibbiy texnikani roʻyxatdan oʻtkazishda Davlat markaziga taqdim etiladigan hujjatlar;</a></div><div class="COMMENT"><label id="s3935"></label><a id="edi-3596072"><a href="/acts/-3594817?ONDATE=15.02.2025 00#edi-7403919">Keyingi</a> tahrirga qarang.</a></div><div class="ACT_TEXT"><a id="-3596073"><strong>dorivor oʻsimlik xomashyosi</strong> — dori vositalarini ishlab chiqarish va tayyorlash uchun foydalaniladigan, tarkibida biologik faol moddalar boʻlgan oʻsimliklar yoki ularning qismlari;</a></div><div class="ACT_TEXT"><a id="-3596074"><strong>retsept</strong> — vrachning farmatsevtik maʼlumotga ega boʻlgan mutaxassisga dori preparatini tayyorlash va (yoki) berish hamda uning qoʻllanilish usuli toʻgʻrisidagi yozma koʻrsatmasi.</a></div><div class="ACT_TEXT"><a id="-3596075">3. Dori vositalari, tibbiy buyumlar va tibbiy texnikani roʻyxatdan oʻtkazish ariza beruvchilarga guvohnoma berilishini nazarda tutadi. </a></div><div class="ACT_TEXT" style="color:#808080;"><a id="-3596076">Dori vositalari, tibbiy buyumlar va tibbiy texnikani roʻyxatdan oʻtkazish va guvohnoma berish Davlat markazi tomonidan ushbu Nizomga<a href="/acts/-3594817#-3596357"> 1-ilovaga </a>muvofiq sxema boʻyicha amalga oshiriladi.</a></div><div class="COMMENT"><label id="s3935"></label><a id="edi-3596076"><a href="/acts/-3594817?ONDATE=15.02.2025 00#edi-7403924">Keyingi</a> tahrirga qarang.</a></div><div class="ACT_TEXT"><a id="-3596077">4. Quyidagilar roʻyxatdan oʻtkaziladi:</a></div><div class="ACT_TEXT"><a id="-3596078">dori vositalari; </a></div><div class="ACT_TEXT"><a id="-3596079">Oʻzbekiston Respublikasida roʻyxatdan oʻtkazilgan dori vositalarining yangi kombinatsiyalari;</a></div><div class="ACT_TEXT"><a id="-3596080">ilgari Oʻzbekiston Respublikasida roʻyxatdan oʻtkazilgan, biroq boshqacha dori shakllarida, dozalarda yoki boshqa ishlab chiqaruvchi tomonidan ishlab chiqarilgan dori vositalari;</a></div><div class="ACT_TEXT"><a id="-3596081">tibbiy buyumlar; </a></div><div class="ACT_TEXT"><a id="-3596082">tibbiy texnika.</a></div><div class="BY_DEFAULT"><a id="-3596083"></a></div><div class="COMMENT"><label id="s3934"></label><a id="edi-6205336"><a href="/acts/-3594817?ONDATE=26.03.2018 00#-6205334">Oldingi</a> tahrirga qarang.</a></div><div class="BY_DEFAULT"><a id="-6205336"></a></div><div class="ACT_TEXT"><a id="-6205337">5. Tarkibida turli dori moddalari boʻlgan dori vositalarini bir xildagi savdo nomi ostida davlat roʻyxatidan oʻtkazishga yoʻl qoʻyilmaydi.</a></div><div class="CHANGES_ORIGINS"><label id="s1104"></label><a id="-6205338">(5-bandning birinchi xatboshisi Oʻzbekiston Respublikasi Vazirlar Mahkamasining 2022-yil 21-sentabrdagi 519-sonli <a href="/acts/-6201435?ONDATE=21.09.2022 00#-6205104">qarori</a> tahririda — Qonunchilik maʼlumotlari milliy bazasi, 21.09.2022-y., 09/22/519/0840-son)</a></div><div class="COMMENT"><label id="s3934"></label><a id="edi-6270042"><a href="/acts/-3594817?ONDATE=21.09.2022 00#-6205340">Oldingi</a> tahrirga qarang.</a></div><div class="BY_DEFAULT"><a id="-6270042"></a></div><div class="ACT_TEXT"><a id="-6270045">Dori vositalarini ishlab chiqarish maqsadida qoʻllaniladigan substansiyalar, dorixonalarda tayyorlanadigan dori vositalari va tibbiy buyumlar, ilmiy-tadqiqot ishlari uchun olib kiriladigan, klinik oldi tadqiqotlar, klinik tadqiqotlar oʻtkazish, koʻrgazmalarda, yarmarkalarda, xalqaro anjumanlarda namoyish etish uchun moʻljallangan dori vositalari, tibbiy buyumlar va tibbiy texnika roʻyxatdan oʻtkazilmaydi.</a></div><div class="CHANGES_ORIGINS"><label id="s1104"></label><a id="-6270050">(5-bandning ikkinchi xatboshisi Oʻzbekiston Respublikasi Prezidentining 2022-yil 26-oktabrdagi PQ-411-sonli <a href="/acts/-6252758?ONDATE=27.10.2022 00#-6254042">qarori</a> tahririda — Qonunchilik maʼlumotlari milliy bazasi, 27.10.2022-y., 07/22/411/0961-son)</a></div><div class="COMMENT"><label id="s3934"></label><a id="edi-6370490"><a href="/acts/-3594817?ONDATE=26.03.2018 00#-3596084">Oldingi</a> tahrirga qarang.</a></div><div class="BY_DEFAULT"><a id="-6370490"></a></div><div class="ACT_TEXT"><a id="-6370492">Bir ishlab chiqaruvchi tomonidan turli savdo nomlari ostida ishlab chiqilgan, tarkibi bir xil boʻlgan dori vositalari roʻyxatdan oʻtkazilishi mumkin.</a></div><div class="CHANGES_ORIGINS"><label id="s1104"></label><a id="-6370500">(5-bandning uchinchi xatboshisi Oʻzbekiston Respublikasi Prezidentining 2023-yil 20-yanvardagi PQ-12-sonli <a href="/acts/-6364824?ONDATE=21.01.2023 00#-6367857">qarori</a> tahririda — Qonunchilik maʼlumotlari milliy bazasi, 21.01.2023-y., 07/23/12/0041)</a></div><div class="COMMENT"><label id="s3934"></label><a id="edi-6205344"><a href="/acts/-3594817?ONDATE=26.03.2018 00#-3596085">Oldingi</a> tahrirga qarang.</a></div><div class="BY_DEFAULT"><a id="-6205344"></a></div><div class="ACT_TEXT"><a id="-6205346">6. Dori vositalarini, tibbiy buyumlarni va tibbiy texnikani davlat roʻyxatidan oʻtkazish natijalariga koʻra xorijiy ishlab chiqaruvchilarga amal qilish muddati besh yil, mahalliy ishlab chiqaruvchilarga muddatsiz boʻlgan tegishli roʻyxatdan oʻtkazilganlik guvohnomasi beriladi.</a></div><div class="CHANGES_ORIGINS"><label id="s1104"></label><a id="-6205350">(6-band Oʻzbekiston Respublikasi Vazirlar Mahkamasining 2022-yil 21-sentabrdagi 519-sonli <a href="/acts/-6201435?ONDATE=21.09.2022 00#-6205109">qarori</a> tahririda — Qonunchilik maʼlumotlari milliy bazasi, 21.09.2022-y., 09/22/519/0840-son)</a></div><div class="COMMENT"><label id="s3934"></label><a id="edi-6270054"><a href="/acts/-3594817?ONDATE=21.09.2022 00#-6270053">Oldingi</a> tahrirga qarang.</a></div><div class="BY_DEFAULT"><a id="-6270054"></a></div><div class="ACT_TEXT"><a id="-6270055">Dori vositalarini davlat roʻyxatidan oʻtkazishda ushbu dori vositasini ishlab chiqarish sharoitlarining “Zarur ishlab chiqarish amaliyoti — GMP” Oʻzbekiston Respublikasi davlat standarti talablariga muvofiqligi yuzasidan joyiga chiqqan holda farmatsevtik inspeksiya oʻtkaziladi (qonunchilik hujjatlari bilan belgilangan alohida holatlar bundan mustasno).</a></div><div class="CHANGES_ORIGINS"><label id="s1104"></label><a id="-6270056">(6-band Oʻzbekiston Respublikasi Prezidentining 2022-yil 26-oktabrdagi PQ-411-sonli <a href="/acts/-6252758?ONDATE=27.10.2022 00#-6254054">qaroriga</a> asosan ikkinchi xatboshi bilan toʻldirilgan — Qonunchilik maʼlumotlari milliy bazasi, 27.10.2022-y., 07/22/411/0961-son)</a></div><div class="ACT_TEXT"><a id="-3596086">7. Guvohnoma dori vositalari, tibbiy buyumlar va tibbiy texnikaning davlat roʻyxatidan oʻtkazilganligini va Oʻzbekiston Respublikasi Sogʻliqni saqlash vazirligi tomonidan tibbiyot amaliyotida qoʻllanilishiga ruxsat berilganligini tasdiqlovchi hujjat hisoblanadi.</a></div><div class="COMMENT"><label id="s3934"></label><a id="edi-6270058"><a href="/acts/-3594817?ONDATE=26.03.2018 00#-6270057">Oldingi</a> tahrirga qarang.</a></div><div class="BY_DEFAULT"><a id="-6270058"></a></div><div class="ACT_TEXT" style="color:#808080;"><a id="-6270059">Davlat markazi tomonidan ariza beruvchining tegishli arizasi taqdim etilishidan qatʼi nazar roʻyxatdan oʻtkazishga taqdim etilgan barcha dori vositalarining referent narxlarini qayd etish ularni davlat roʻyxatidan oʻtkazish jarayonida amalga oshiriladi.</a></div><div class="COMMENT"><label id="s3935"></label><a id="edi-6270059"><a href="/acts/-3594817?ONDATE=15.02.2025 00#edi-7403934">Keyingi</a> tahrirga qarang.</a></div><div class="BY_DEFAULT" style="color:#808080;"><a id="-6270060"></a></div><div class="ACT_TEXT" style="color:#808080;"><a id="-7403939">Davlat markazi tomonidan ariza beruvchining tegishli arizasi taqdim etilishidan qatʼi nazar Tibbiyot amaliyotida qoʻllanilishiga ruxsat etilgan dori vositalari, tibbiy buyumlar va tibbiy texnika davlat reyestriga kiritilgan barcha dori vositalarining referent narxlari qayd etiladi.</a></div><div class="CHANGES_ORIGINS" style="color:#808080;"><label id="s1104"></label><a id="-6270061">(7-band Oʻzbekiston Respublikasi Prezidentining 2022-yil 26-oktabrdagi PQ-411-sonli <a href="/acts/-6252758?ONDATE=27.10.2022 00#-6254061">qaroriga</a> asosan ikkinchi va uchinchi xatboshilar bilan toʻldirilgan — Qonunchilik maʼlumotlari milliy bazasi, 27.10.2022-y., 07/22/411/0961-son)</a></div><div class="COMMENT"><label id="s3935"></label><a id="edi-6270061"><a href="/acts/-3594817?ONDATE=15.02.2025 00#edi-7403940">Keyingi</a> tahrirga qarang.</a></div><div class="COMMENT"><label id="s3934"></label><a id="edi-5810772"><a href="/acts/-3594817?ONDATE=26.03.2018 00#-3596087">Oldingi</a> tahrirga qarang.</a></div><div class="BY_DEFAULT"><a id="-5810772"></a></div><div class="ACT_TEXT"><a id="-5810780">8. Tashqi begʻaraz koʻmak, grant mablagʻlari hisobiga hamda insonparvarlik yordami sifatida kirib kelayotgan dori vositalari, tibbiy buyumlar va tibbiy texnikalar davlat roʻyxatidan oʻtkazilmasdan Oʻzbekiston Respublikasi hududiga kiritilishiga va foydalanishga ruxsat beriladi.</a></div><div class="ACT_TEXT"><a id="-5810786">Bunda, dori vositalari, tibbiy buyumlar va tibbiy texnikalarni Oʻzbekiston Respublikasi hududiga olib kirilishiga va foydalanishga Oʻzbekiston Respublikasi Sogʻliqni saqlash vazirligi tomonidan tegishli xulosa beriladi.</a></div><div class="CHANGES_ORIGINS"><label id="s1104"></label><a id="-5810805">(8-band Oʻzbekiston Respublikasi Vazirlar Mahkamasining 2021-yil 29-dekabrdagi 786-sonli <a href="/acts/-5799388?ONDATE=29.12.2021 00#-5804028">qarori </a>tahririda — Qonunchilik maʼlumotlari milliy bazasi, 29.12.2021-y., 09/21/786/1216-son)</a></div><div class="TEXT_HEADER_DEFAULT"><a id="-3596088">2-bob. Ruxsat berishga doir talablar va shartlar</a></div><div class="ACT_TEXT"><a id="-3596089">9. Dori vositalari, tibbiy buyumlar va tibbiy texnikani roʻyxatdan oʻtkazilganlik guvohnomasi asosida tibbiyot amaliyotida qoʻllanilishida ariza beruvchi tomonidan bajarilishi shart boʻlgan talablar va shartlar quyidagilardan iborat:</a></div><div class="ACT_TEXT"><a id="-3596090">dori vositalari, tibbiy buyumlar va tibbiy texnikani roʻyxatdan oʻtkazish uchun murojaat qilgan ariza beruvchi tomonidan ularning tibbiyot amaliyotida qoʻllanilishida qonun hujjatlariga soʻzsiz rioya etish;</a></div><div class="ACT_TEXT" style="color:#808080;"><a id="-3596091">guvohnomaning amal qilish davrida ariza beruvchi tomonidan Davlat markaziga roʻyxatdan oʻtkazish hujjatlariga oʻzgartirish yoki qoʻshimchalar kiritish toʻgʻrisidagi toʻliq maʼlumotlarni taqdim etish;</a></div><div class="COMMENT"><label id="s3935"></label><a id="edi-3596091"><a href="/acts/-3594817?ONDATE=15.02.2025 00#edi-7403944">Keyingi</a> tahrirga qarang.</a></div><div class="ACT_TEXT"><a id="-3596092">dori vositalari, tibbiy buyumlar va tibbiy texnikaga doir texnik jihatdan tartibga solish sohasidagi normativ hujjatlar (keyingi oʻrinlarda normativ hujjatlar deb ataladi) talablariga, dori vositalari, tibbiy buyumlar va tibbiy texnikani roʻyxatdan oʻtkazish hujjatlarida keltirilgan maʼlumotlarga qatʼiy rioya etish;</a></div><div class="ACT_TEXT" style="color:#808080;"><a id="-3596093">Davlat markazi tomonidan koʻrsatilgan kamchiliklarni oʻz vaqtida bartaraf etish, shuningdek, dori vositalari, tabiiy buyumlar va tibbiy texnika namunalarini hamda boshqa materiallarni ushbu Nizomning <a href="/acts/-3594817#-3596113">15-bandida </a>nazarda tutilgan muddatlarda taqdim etish.</a></div><div class="COMMENT"><label id="s3935"></label><a id="edi-3596093"><a href="/acts/-3594817?ONDATE=15.02.2025 00#edi-7403956">Keyingi</a> tahrirga qarang.</a></div><div class="TEXT_HEADER_DEFAULT"><a id="-3596094">3-bob. Guvohnomani olish uchun zarur boʻlgan hujjatlar va namunalar</a></div><div class="BY_DEFAULT"><a id="-3596095"></a></div><div class="ACT_TEXT" style="color:#808080;"><a id="-7403967">10. Guvohnomani olish uchun ariza beruvchi Davlat markaziga quyidagilarni taqdim etadi:</a></div><div class="COMMENT"><label id="s3935"></label><a id="edi-7403967"><a href="/acts/-3594817?ONDATE=15.02.2025 00#edi-7403968">Keyingi</a> tahrirga qarang.</a></div><div class="ACT_TEXT"><a id="-3596096">a) ushbu Nizomning 2- (dori vositalari uchun) va 2a- (tibbiy buyumlar va tibbiy texnika uchun) ilovalariga<a href="/acts/-3594817#-3597452">* </a>muvofiq shakl boʻyicha ariza;</a></div><div class="COMMENT"><label id="s3934"></label><a id="edi-6270062"><a href="/acts/-3594817?ONDATE=11.08.2019 00#-4482445">Oldingi</a> tahrirga qarang.</a></div><div class="BY_DEFAULT"><a id="-6270062"></a></div><div class="ACT_TEXT"><a id="-6270063">b) ushbu Nizomning 3 (dori vositalari uchun) va 3a (tibbiy buyumlar va tibbiy texnika uchun) ilovalarida<a href="/acts/-3594817#-3597452">*</a> nazarda tutilgan ketma-ketlikda har birini alohida yuklagan holda tegishli ravishda ariza beruvchining elektron imzosi bilan tasdiqlangan dori vositalari, tibbiy buyumlar yoki tibbiy texnikani roʻyxatdan oʻtkazish hujjatlarining elektron shakli;</a></div><div class="CHANGES_ORIGINS"><label id="s1104"></label><a id="-6270067">(10-bandning “b” kichik bandi  Oʻzbekiston Respublikasi Prezidentining 2022-yil 26-oktabrdagi PQ-411-sonli <a href="/acts/-6252758?ONDATE=27.10.2022 00#-6254070">qarori</a> tahririda — Qonunchilik maʼlumotlari milliy bazasi, 27.10.2022-y., 07/22/411/0961-son)</a></div><div class="ACT_TEXT"><a id="-3596098">v) dori vositasining uch marotaba sinovlar oʻtkazilishi uchun zarur boʻlgan miqdordagi bir sanoat seriyasidagi namunalari;</a></div><div class="ACT_TEXT"><a id="-3596099">g) tibbiy buyumlar va tibbiy texnikaning normativ hujjatlarga muvofiq sinovlar oʻtkazilishi uchun zarur boʻlgan miqdordagi namunalari;</a></div><div class="COMMENT"><label id="s3934"></label><a id="edi-6270070"><a href="/acts/-3594817?ONDATE=26.03.2018 00#-3596100">Oldingi</a> tahrirga qarang.</a></div><div class="BY_DEFAULT"><a id="-6270070"></a></div><div class="ACT_TEXT"><a id="-6270071">d) faol taʼsir etuvchi moddalarning hamda yot va oʻxshash moddalarning standart namunalari, nazorat materiallari, maxsus reaktivlar va ular sifatini tasdiqlovchi hujjatlar.</a></div><div class="CHANGES_ORIGINS"><label id="s1104"></label><a id="-6270072">(10-bandning “d” kichik bandi Oʻzbekiston Respublikasi Prezidentining 2022-yil 26-oktabrdagi PQ-411-sonli <a href="/acts/-6252758?ONDATE=27.10.2022 00#-6254076">qarori</a> tahririda — Qonunchilik maʼlumotlari milliy bazasi, 27.10.2022-y., 07/22/411/0961-son)</a></div><div class="COMMENT"><label id="s3934"></label><a id="edi-7093085"><a href="/acts/-3594817?ONDATE=26.03.2018 00#-7093084">Oldingi</a> tahrirga qarang.</a></div><div class="BY_DEFAULT"><a id="-7093085"></a></div><div class="ACT_TEXT"><a id="-7093088">e) dori vositalari, tibbiy buyumlar va tibbiy texnikada qoʻllanilgan intellektual mulk obyektlariga (tovar belgilari va sanoat namunalari) (keyingi oʻrinlarda — IMO) boʻlgan huquqlarni tasdiqlovchi muhofaza hujjati (guvohnoma, patent va ularga ilova) yoki ulardan foydalanish toʻgʻrisidagi shartnoma, agar mavjud boʻlsa;</a></div><div class="CHANGES_ORIGINS"><label id="s1104"></label><a id="-7093090">(10-band Oʻzbekiston Respublikasi Vazirlar Mahkamasining 2024-yil 31-avgustdagi 535-sonli <a href="/acts/-7090221?ONDATE=04.09.2024 00#-7090632">qaroriga </a>asosan “e” kichik band bilan toʻldirilgan — Qonunchilik maʼlumotlari milliy bazasi, 04.09.2024-y., 09/24/535/0679-son)</a></div><div class="ACT_TEXT"><a id="-3596101">Davlat roʻyxatidan oʻtkazishga taqdim etilgan dori vositalarining klinik tadqiqotlarini oʻtkazishda GCP (zarur tarzdagi klinika amaliyoti) qoidalariga muvofiq ariza beruvchi tomonidan klinik bazalarga (davolash-profilaktika muassasalariga) dori vositalarining klinik tadqiqotlar oʻtkazish uchun zarur boʻlgan hujjatlari (klinik tadqiqotlar bayonnomasi, tadqiqotchi broshyurasi va boshqalar) va namunalari taqdim etiladi.</a></div><div class="ACT_TEXT"><a id="-3596102">11. Ariza beruvchidan ushbu Nizomning <a href="/acts/-3594817#-3596095">10-bandida </a>nazarda tutilmagan hujjatlar va namunalar taqdim etilishini talab qilishga yoʻl qoʻyilmaydi.</a></div><div class="BY_DEFAULT"><a id="-3596103"></a></div><div class="COMMENT"><label id="s3934"></label><a id="edi-6270075"><a href="/acts/-3594817?ONDATE=26.03.2018 00#-6270074">Oldingi</a> tahrirga qarang.</a></div><div class="BY_DEFAULT" style="color:#808080;"><a id="-6270075"></a></div><div class="ACT_TEXT" style="color:#808080;"><a id="-6270076">12. Guvohnomani olish uchun zarur boʻlgan hujjatlar Davlat markaziga elektron shaklda, Davlat markazining elektron tizimi orqali ular olinganligi haqidagi xabarnomani olgan holda taqdim etiladi. Taqdim etilgan hujjatlar ariza beruvchining elektron raqamli imzosi bilan tasdiqlanadi.</a></div><div class="CHANGES_ORIGINS" style="color:#808080;"><label id="s1104"></label><a id="-6270079">(12-bandning birinchi xatboshisi Oʻzbekiston Respublikasi Prezidentining 2022-yil 26-oktabrdagi PQ-411-sonli <a href="/acts/-6252758?ONDATE=27.10.2022 00#-6254140">qarori</a> tahririda — Qonunchilik maʼlumotlari milliy bazasi, 27.10.2022-y., 07/22/411/0961-son)</a></div><div class="COMMENT"><label id="s3935"></label><a id="edi-6270079"><a href="/acts/-3594817?ONDATE=15.02.2025 00#edi-7403989">Keyingi</a> tahrirga qarang.</a></div><div class="ACT_TEXT"><a id="-3596104">Dori vositalari, tibbiy buyumlar va tibbiy texnika namunalari bevosita yoki pochta aloqasi vositalari orqali taqdim etiladi.</a></div><div class="ACT_TEXT" style="color:#808080;"><a id="-3596105">13. Davlat markazi roʻyxatdan oʻtkazish hujjatlaridagi maxfiy maʼlumotlarning oshkor qilinishi uchun javob beradi.</a></div><div class="COMMENT"><label id="s3935"></label><a id="edi-3596105"><a href="/acts/-3594817?ONDATE=15.02.2025 00#edi-7403995">Keyingi</a> tahrirga qarang.</a></div><div class="TEXT_HEADER_DEFAULT"><a id="-3596107">4-bob. Arizani koʻrib chiqish, guvohnoma berish yoki uni berishni rad etish toʻgʻrisida qaror qabul qilish</a></div><div class="BY_DEFAULT"><a id="-3596108"></a></div><div class="COMMENT"><label id="s3934"></label><a id="edi-4720153"><a href="/acts/-3594817?ONDATE=26.03.2018 00#-4720152">Oldingi</a> tahrirga qarang.</a></div><div class="BY_DEFAULT"><a id="-4720153"></a></div><div class="ACT_TEXT"><a id="-4720154">14. Guvohnoma berish toʻgʻrisidagi ariza koʻrib chiqilganligi uchun ariza berilgan kundagi bazaviy hisoblash miqdorining 10 barobari miqdorida yigʻim undiriladi.</a></div><div class="CHANGES_ORIGINS"><label id="s1104"></label><a id="-4720155">(14-bandning birinchi xatboshisi Oʻzbekiston Respublikasi Vazirlar Mahkamasining 2019-yil 28-dekabrdagi 1046-sonli <a href="/acts/-4671960?ONDATE=29.12.2019 00#-4684210">qarori </a>tahririda — Qonun hujjatlari maʼlumotlari milliy bazasi, 29.12.2019-y., 09/19/1046/4242-son)</a></div><div class="ACT_TEXT" style="color:#808080;"><a id="-3596109">Yigʻim summasi Davlat markazi hisob raqamiga oʻtkaziladi. </a></div><div class="COMMENT"><label id="s3935"></label><a id="edi-3596109"><a href="/acts/-3594817?ONDATE=15.02.2025 00#edi-7404006">Keyingi</a> tahrirga qarang.</a></div><div class="ACT_TEXT"><a id="-3596110">Ariza beruvchi bergan arizasidan voz kechgan taqdirda toʻlangan yigʻim summasi qaytarilmaydi.</a></div><div class="ACT_TEXT" style="color:#808080;"><a id="-3596112">Dori vositalari, tibbiy buyumlar va tibbiy texnikaning xorijiy ishlab chiqaruvchisining (yoki uning nomidan harakat qiluvchi ishonchli vakilning) arizasini koʻrib chiqish va guvohnoma berish, unga oʻzgartirish va qoʻshimchalar kiritish, guvohnomaning amal qilish muddatini uzaytirish, uni qayta rasmiylashtirish va dublikat berish toʻgʻrisidagi arizasini koʻrib chiqish uchun yigʻim summasi Davlat markazining koʻrsatib oʻtilgan tartibotlarni amalga oshirish uchun ketgan xarajatlari asosida Oʻzbekiston Respublikasi Sogʻliqni saqlash vazirligi tomonidan tasdiqlanadigan preyskurantga koʻra amalga oshiriladi. </a></div><div class="COMMENT"><label id="s3935"></label><a id="edi-3596112"><a href="/acts/-3594817?ONDATE=15.02.2025 00#edi-7404019">Keyingi</a> tahrirga qarang.</a></div><div class="BY_DEFAULT"><a id="-3596113"></a></div><div class="ACT_TEXT" style="color:#808080;"><a id="-7404033">15. Guvohnoma berish toʻgʻrisidagi ariza Davlat markazi tomonidan ariza quyidagilardan oshmaydigan muddatlarda koʻrib chiqiladi:</a></div><div class="COMMENT"><label id="s3935"></label><a id="edi-7404033"><a href="/acts/-3594817?ONDATE=15.02.2025 00#edi-7404035">Keyingi</a> tahrirga qarang.</a></div><div class="COMMENT"><label id="s3934"></label><a id="edi-6270081"><a href="/acts/-3594817?ONDATE=06.05.2021 00#-5426512">Oldingi</a> tahrirga qarang.</a></div><div class="BY_DEFAULT"><a id="-6270081"></a></div><div class="ACT_TEXT"><a id="-6270084">15 ish kuni — tan olish yoʻli bilan roʻyxatdan oʻtkaziladigan dori vositalari, tibbiy texnika, tibbiy buyumlar va ularning butlovchi qismlari;</a></div><div class="CHANGES_ORIGINS"><label id="s1104"></label><a id="-6270088">(15-bandning ikkinchi xatboshisi Oʻzbekiston Respublikasi Prezidentining 2022-yil 26-oktabrdagi PQ-411-sonli <a href="/acts/-6252758?ONDATE=27.10.2022 00#-6254146">qarori</a> tahririda — Qonunchilik maʼlumotlari milliy bazasi, 27.10.2022-y., 07/22/411/0961-son)</a></div><div class="ACT_TEXT"><a id="-3596114">50 kun — dori moddalari (substansiyalar) uchun;</a></div><div class="COMMENT"><label id="s3934"></label><a id="edi-5384323"><a href="/acts/-3594817?ONDATE=26.03.2018 00#-5384316">Oldingi</a> tahrirga qarang.</a></div><div class="BY_DEFAULT"><a id="-5384323"></a></div><div class="ACT_TEXT"><a id="-5384330">60 kun – Jahon sogʻliqni saqlash tashkiloti tomonidan qayta malakalangan dori preparatlari va “in vitro” tashxis tibbiy buyumlari uchun;</a></div><div class="CHANGES_ORIGINS"><label id="s1104"></label><a id="-5384348">(15-band Oʻzbekiston Respublikasi Vazirlar Mahkamasining 2019-yil 17-avgustdagi 678-sonli <a href="/acts/-4477408?ONDATE=17.08.2019 00#-4480953">qaroriga </a>asosan uchinchi xatboshi bilan toʻldirilgan — Qonun hujjatlari maʼlumotlari milliy bazasi, 17.08.2019-y., 09/19/678/3577-son)</a></div><div class="ACT_TEXT"><a id="-3596115">120 kun — qadoqlangan va oʻrash-joylash materialiga joylangan farmakopeya dorivor oʻsimlik xomashyosi shaklidagi dori vositalari, bogʻlov materiallari, teshish, inyeksiya, transfuziya va soʻrib olishga moʻljallangan buyumlar, kontratseptivlar, rezina, rezina mato, lateks, polimerdan tayyorlangan tibbiy buyumlar, bemorlarga birinchi tibbiy yordam koʻrsatish, bemorlarni parvarish qilish uchun tibbiy buyumlar. </a></div><div class="ACT_TEXT"><a id="-3596116">155 kun — qolgan dori vositalari, tibbiy buyumlar va tibbiy texnika uchun.</a></div><div class="ACT_TEXT"><a id="-3596117">Quyidagi muddatlar yuqorida koʻrsatilgan muddatlarga kiritilmaydi:</a></div><div class="ACT_TEXT"><a id="-3596118">dori vositalari, tibbiy buyumlar va tibbiy texnikani ekspertizadan oʻtkazish jarayonida aniqlangan kamchiliklarni bartaraf etish uchun belgilangan 45 kundan oshmaydigan muddat;</a></div><div class="ACT_TEXT"><a id="-3596119">klinik sinovlar oʻtkazish uchun klinik bazalarga ariza beruvchi tomonidan tegishli tartibda kelishilgan klinik sinovlar dasturlarini, dori vositalari, tibbiy buyumlar va tibbiy texnika namunalarini taqdim etish uchun belgilangan 45 kundan oshmaydigan muddat;</a></div><div class="ACT_TEXT"><a id="-3596120">jenerik dori vositalarining klinik tadqiqotlarini oʻtkazishning bevosita bir yildan oshmaydigan, original dori vositalarining klinik tadqiqotlarini oʻtkazishning uch yildan oshmaydigan muddatlari.</a></div><div class="COMMENT"><label id="s3934"></label><a id="edi-5384374"><a href="/acts/-3594817?ONDATE=26.03.2018 00#-3596121">Oldingi</a> tahrirga qarang.</a></div><div class="BY_DEFAULT"><a id="-5384374"></a></div><div class="ACT_TEXT"><a id="-5384376">Dori moddalarini (substansiyalar) va Jahon sogʻliqni saqlash tashkiloti tomonidan qayta malakalangan dori preparatlarini roʻyxatdan oʻtkazishda klinik tadqiqotlar oʻtkazilmaydi.</a></div><div class="CHANGES_ORIGINS"><label id="s1104"></label><a id="-5384384">(15-bandning oʻninchi xatboshisi Oʻzbekiston Respublikasi Vazirlar Mahkamasining 2019-yil 17-avgustdagi 678-sonli <a href="/acts/-4477408?ONDATE=17.08.2019 00#-4480968">qarori</a> tahririda — Qonun hujjatlari maʼlumotlari milliy bazasi, 17.08.2019-y., 09/19/678/3577-son)</a></div><div class="COMMENT"><label id="s3934"></label><a id="edi-6270090"><a href="/acts/-3594817?ONDATE=06.05.2021 00#-5426519">Oldingi</a> tahrirga qarang.</a></div><div class="BY_DEFAULT"><a id="-6270090"></a></div><div class="ACT_TEXT"><a id="-6270091">Jahon sogʻliqni saqlash tashkiloti tomonidan qayta malakalangan dori vositalari va “in vitro” tashxis tibbiy buyumlari, tan olish yoʻli bilan roʻyxatdan oʻtkaziladigan dori vositalari, tibbiy texnika, tibbiy buyumlar va ularning butlovchi qismlarini roʻyxatdan oʻtkazishda laboratoriya sinovlari oʻtkazilmaydi.</a></div><div class="CHANGES_ORIGINS"><label id="s1104"></label><a id="-6270092">(15-bandning oʻn ikkinchi xatboshisi Oʻzbekiston Respublikasi Prezidentining 2022-yil 26-oktabrdagi PQ-411-sonli <a href="/acts/-6252758?ONDATE=27.10.2022 00#-6254146">qarori</a> tahririda — Qonunchilik maʼlumotlari milliy bazasi, 27.10.2022-y., 07/22/411/0961-son)</a></div><div class="COMMENT"><label id="s3934"></label><a id="edi-5592310"><a href="/acts/-3594817?ONDATE=26.03.2018 00#-5592309">Oldingi</a> tahrirga qarang.</a></div><div class="BY_DEFAULT"><a id="-5592310"></a></div><div class="ACT_TEXT"><a id="-5592311">Oʻsma kasalliklarini immunogistokimyoviy, molekulyar va genetik tekshirishlar uchun reagentlarni roʻyxatdan oʻtkazishda klinik-laboratoriyaviy sinovlar oʻtkazilmaydi.</a></div><div class="CHANGES_ORIGINS"><label id="s1104"></label><a id="-5592316">(15-band Oʻzbekiston Respublikasi Vazirlar Mahkamasining 2021-yil 3-avgustdagi 486-sonli <a href="/acts/-5546536?ONDATE=03.08.2021 00#-5553392">qaroriga</a> xatboshi bilan toʻldirilgan — Qonunchilik maʼlumotlari milliy bazasi, 03.08.2021-y., 09/21/486/0748-son)</a></div><div class="COMMENT"><label id="s3934"></label><a id="edi-4720156"><a href="/acts/-3594817?ONDATE=26.03.2018 00#-3596123">Oldingi</a> tahrirga qarang.</a></div><div class="BY_DEFAULT" style="color:#808080;"><a id="-4720156"></a></div><div class="ACT_TEXT" style="color:#808080;"><a id="-4720157">16. Guvohnoma berish uchun bazaviy hisoblash miqdorining ikki barobari miqdorida yigʻim undiriladi. Yigʻim summasi Davlat markazi hisobraqamiga oʻtkaziladi.</a></div><div class="CHANGES_ORIGINS" style="color:#808080;"><label id="s1104"></label><a id="-4720158">(16-band Oʻzbekiston Respublikasi Vazirlar Mahkamasining 2019-yil 28-dekabrdagi 1046-sonli <a href="/acts/-4671960?ONDATE=29.12.2019 00#-4684211">qarori </a>tahririda — Qonun hujjatlari maʼlumotlari milliy bazasi, 29.12.2019-y., 09/19/1046/4242-son)</a></div><div class="COMMENT"><label id="s3935"></label><a id="edi-4720158"><a href="/acts/-3594817?ONDATE=15.02.2025 00#edi-7404040">Keyingi</a> tahrirga qarang.</a></div><div class="ACT_TEXT" style="color:#808080;"><a id="-3596124">17. Davlat markazi tegishli qaror qabul qilingan kundan boshlab bir ish kunidan kechiktirmay ariza beruvchiga guvohnomani berishi (yuborishi) yoki bunday hujjatni berishning rad etilganligi toʻgʻrisida uni yozma shaklda, jumladan axborot tizimi orqali elektron shaklda xabardor qilishi kerak.</a></div><div class="COMMENT"><label id="s3935"></label><a id="edi-3596124"><a href="/acts/-3594817?ONDATE=15.02.2025 00#edi-7404046">Keyingi</a> tahrirga qarang.</a></div><div class="BY_DEFAULT"><a id="-3596125"></a></div><div class="COMMENT"><label id="s3934"></label><a id="edi-7093096"><a href="/acts/-3594817?ONDATE=26.03.2018 00#-7093095">Oldingi</a> tahrirga qarang.</a></div><div class="BY_DEFAULT" style="color:#808080;"><a id="-7093096"></a></div><div class="ACT_TEXT" style="color:#808080;"><a id="-7093097">18. Davlat markazi dori vositalari, tibbiy buyumlar va tibbiy texnikani roʻyxatdan oʻtkazish hujjatlarini baholash doirasida ishlab chiqarish sharoitlarini, dori vositalari, tibbiy buyumlar va tibbiy texnikaning normativ hujjatlar talablariga muvofiqligini, sifati, samaradorligi va xavfsizligi, qoʻllashda kutilayotgan samaraning inson salomatligi xavfiga nisbatini, IMOga boʻlgan huquqlarga rioya etilganligini dori vositalari, tibbiy buyumlar va tibbiy texnikani roʻyxatdan oʻtkazish toʻgʻrisida qaror qabul qilish maqsadida mustaqil ravishda yoki uchinchi shaxslarni yoxud mustaqil ekspertlarni jalb etgan holda quyidagi ekspertiza ishlari, tekshiruvlar, sinovlar, tahlillar, tadqiqotlar, oʻrganishlar va ilmiy-texnik baholashlarni oʻtkazishi mumkin:</a></div><div class="CHANGES_ORIGINS" style="color:#808080;"><label id="s1104"></label><a id="-7093098">(18-bandning birinchi xatboshisi Oʻzbekiston Respublikasi Vazirlar Mahkamasining 2024-yil 31-avgustdagi 535-sonli <a href="/acts/-7090221?ONDATE=04.09.2024 00#-7090635">qarori </a>tahririda — Qonunchilik maʼlumotlari milliy bazasi, 04.09.2024-y., 09/24/535/0679-son)</a></div><div class="COMMENT"><label id="s3935"></label><a id="edi-7093098"><a href="/acts/-3594817?ONDATE=15.02.2025 00#edi-7404057">Keyingi</a> tahrirga qarang.</a></div><div class="ACT_TEXT"><a id="-3596126">dori vositalari, tibbiy buyumlar va tibbiy texnikaning roʻyxatdan oʻtkazish hujjatlari ekspertizasi;</a></div><div class="ACT_TEXT"><a id="-3596128">dori vositalari, tibbiy buyumlar va tibbiy texnikani ishlab chiqarish sharoitlarining ishlab chiqarishni tashkil etish va sifat nazoratini olib borish qoidalari talablariga muvofiqligini, sifatni boshqarish tizimini baholash va aniqlash maqsadida inspeksion tekshiruvlar; </a></div><div class="ACT_TEXT"><a id="-3596129">dori vositalari, tibbiy buyumlar va tibbiy texnika namunalarining sinovlari va tadqiqotlari;</a></div><div class="ACT_TEXT"><a id="-3596130">tarkibida giyohvandlik vositalari, psixotrop moddalar va prekursorlar boʻlgan dori vositalari hujjatlari ekspertizasi;</a></div><div class="ACT_TEXT"><a id="-3596131">farmakologik, toksikologik tadqiqotlar;</a></div><div class="ACT_TEXT"><a id="-3596132">klinikagacha tadqiqotlar, bioekvivalentlik sinovlar;</a></div><div class="COMMENT"><label id="s3934"></label><a id="edi-7093100"><a href="/acts/-3594817?ONDATE=26.03.2018 00#-7093099">Oldingi</a> tahrirga qarang.</a></div><div class="BY_DEFAULT"><a id="-7093100"></a></div><div class="ACT_TEXT"><a id="-7093101">IMOga boʻlgan huquqlarni tasdiqlovchi muhofaza hujjati (guvohnoma, patent va ularga ilova) yoki ulardan foydalanish toʻgʻrisidagi shartnoma mavjud boʻlmaganda, dori vositalari, tibbiy buyumlar va tibbiy texnikada IMOga boʻlgan huquqlarga rioya etilganligini tekshirish.</a></div><div class="CHANGES_ORIGINS"><label id="s1104"></label><a id="-7093102">(18-band Oʻzbekiston Respublikasi Vazirlar Mahkamasining 2024-yil 31-avgustdagi 535-sonli <a href="/acts/-7090221?ONDATE=04.09.2024 00#-7090637">qaroriga </a>asosan sakkizinchi xatboshi bilan toʻldirilgan — Qonunchilik maʼlumotlari milliy bazasi, 04.09.2024-y., 09/24/535/0679-son)</a></div><div class="COMMENT"><label id="s3934"></label><a id="edi-7093104"><a href="/acts/-3594817?ONDATE=26.03.2018 00#-7093103">Oldingi</a> tahrirga qarang.</a></div><div class="BY_DEFAULT"><a id="-7093104"></a></div><div class="ACT_TEXT"><a id="-7093107">18<sup>1</sup>. IMOga boʻlgan huquqlarga rioya etilganligini tekshirishlar dori vositalari, tibbiy buyumlar va tibbiy texnika namunalarida qoʻllanilgan nom, belgi va tashqi koʻrinish Adliya vazirligining Sanoat mulki muhofazasi portalida tegishli ravishda tovar belgisi va sanoat namunasiga taalluqli mavjud maʼlumotlar bilan solishtirish orqali amalga oshiriladi.</a></div><div class="CHANGES_ORIGINS"><label id="s1104"></label><a id="-7093108">(18<sup>1</sup>-band Oʻzbekiston Respublikasi Vazirlar Mahkamasining 2024-yil 31-avgustdagi 535-sonli <a href="/acts/-7090221?ONDATE=04.09.2024 00#-7090640">qaroriga </a>asosan kiritilgan — Qonunchilik maʼlumotlari milliy bazasi, 04.09.2024-y., 09/24/535/0679-son)</a></div><div class="BY_DEFAULT"><a id="-3596134"></a></div><div class="ACT_TEXT" style="color:#808080;"><a id="-7404075">19. Roʻyxatdan oʻtkazish Davlat markazi tomonidan ushbu Nizomga<a href="/acts/-3594817#-3596357"> 1-ilovada </a>koʻrsatilgan muddatlarda quyidagi tartibda amalga oshiriladi:</a></div><div class="COMMENT"><label id="s3935"></label><a id="edi-7404075"><a href="/acts/-3594817?ONDATE=15.02.2025 00#edi-7404077">Keyingi</a> tahrirga qarang.</a></div><div class="ACT_TEXT"><a id="-3596136">a) Roʻyxatdan oʻtkazish boʻlimi:</a></div><div class="COMMENT"><label id="s3934"></label><a id="edi-7093109"><a href="/acts/-3594817?ONDATE=26.03.2018 00#-3596138">Oldingi</a> tahrirga qarang.</a></div><div class="BY_DEFAULT"><a id="-7093109"></a></div><div class="ACT_TEXT"><a id="-7093110">ariza qabul qilingandan soʻng ariza hamda unga ilova qilingan roʻyxatdan oʻtkazish hujjatlarini va dori vositalari, tibbiy buyumlar va tibbiy texnikaning namunalarini birlamchi (dastlabki) ekspertizadan oʻtkazadi hamda dori vositalari, tibbiy buyumlar va tibbiy texnikada IMOga boʻlgan huquqlarga rioya etilganligini tekshiradi;</a></div><div class="CHANGES_ORIGINS"><label id="s1104"></label><a id="-7093111">(19-band “a” kichik bandining ikkinchi xatboshisi Oʻzbekiston Respublikasi Vazirlar Mahkamasining 2024-yil 31-avgustdagi 535-sonli <a href="/acts/-7090221?ONDATE=04.09.2024 00#-7090643">qarori </a>tahririda — Qonunchilik maʼlumotlari milliy bazasi, 04.09.2024-y., 09/24/535/0679-son)</a></div><div class="ACT_TEXT"><a id="-3596139">dori vositalari, tibbiy buyumlar va tibbiy texnikani roʻyxatdan oʻtkazish masalalari boʻyicha ariza beruvchi bilan tegishli yozishmalar olib boradi;</a></div><div class="COMMENT"><label id="s3934"></label><a id="edi-7093112"><a href="/acts/-3594817?ONDATE=26.03.2018 00#-3596141">Oldingi</a> tahrirga qarang.</a></div><div class="BY_DEFAULT" style="color:#808080;"><a id="-7093112"></a></div><div class="ACT_TEXT" style="color:#808080;"><a id="-7093113">birlamchi (dastlabki) ekspertiza hamda dori vositalari, tibbiy buyumlar va tibbiy texnikada IMOga boʻlgan huquqlarga rioya etilganligi yuzasidan tekshirishlarning ijobiy natijalari asosida Davlat markazi va ariza beruvchi oʻrtasida shartnoma tuzilishini taʼminlaydi va toʻlov varaqasini rasmiylashtiradi;</a></div><div class="CHANGES_ORIGINS" style="color:#808080;"><label id="s1104"></label><a id="-7093114">(19-band “a” kichik bandining toʻrtinchi xatboshisi Oʻzbekiston Respublikasi Vazirlar Mahkamasining 2024-yil 31-avgustdagi 535-sonli <a href="/acts/-7090221?ONDATE=04.09.2024 00#-7090643">qarori </a>tahririda — Qonunchilik maʼlumotlari milliy bazasi, 04.09.2024-y., 09/24/535/0679-son)</a></div><div class="COMMENT"><label id="s3935"></label><a id="edi-7093114"><a href="/acts/-3594817?ONDATE=15.02.2025 00#edi-7404089">Keyingi</a> tahrirga qarang.</a></div><div class="COMMENT"><label id="s3934"></label><a id="edi-5384455"><a href="/acts/-3594817?ONDATE=26.03.2018 00#-3596145">Oldingi</a> tahrirga qarang.</a></div><div class="BY_DEFAULT" style="color:#808080;"><a id="-5384455"></a></div><div class="ACT_TEXT" style="color:#808080;"><a id="-5384460">belgilangan yigʻim summasi ariza beruvchi tomonidan toʻlangandan keyin ariza hamda ilova qilinadigan namunalar va hujjatlarni ekspertizadan oʻtkazish uchun Davlat markazining laboratoriyalariga (Jahon sogʻliqni saqlash tashkiloti tomonidan qayta malakalangan dori preparatlari va “in vitro” tashxis tibbiy buyumlari bundan mustasno), Farmakologiya, Farmakopeya, Yangi tibbiy texnika qoʻmitalariga, Narkotiklarni nazorat qilish qoʻmitasiga (dori vositalari tarkibida giyohvand vositalar, psixotrop moddalar va prekursorlar mavjud boʻlgan taqdirda) taqdim etadi;</a></div><div class="CHANGES_ORIGINS" style="color:#808080;"><label id="s1104"></label><a id="-5384467">(19-band “a” kichik bandining beshinchi xatboshisi Oʻzbekiston Respublikasi Vazirlar Mahkamasining 2019-yil 17-avgustdagi 678-sonli <a href="/acts/-4477408?ONDATE=17.08.2019 00#-4480974">qarori </a>tahririda — Qonun hujjatlari maʼlumotlari milliy bazasi, 17.08.2019-y., 09/19/678/3577-son)</a></div><div class="COMMENT"><label id="s3935"></label><a id="edi-5384467"><a href="/acts/-3594817?ONDATE=15.02.2025 00#edi-7404102">Keyingi</a> tahrirga qarang.</a></div><div class="BY_DEFAULT"><a id="-3596146"></a></div><div class="ACT_TEXT" style="color:#808080;"><a id="-7404115">b) Davlat markazi laboratoriyalari:</a></div><div class="COMMENT"><label id="s3935"></label><a id="edi-7404115"><a href="/acts/-3594817?ONDATE=15.02.2025 00#edi-7404116">Keyingi</a> tahrirga qarang.</a></div><div class="ACT_TEXT"><a id="-3596147">dori vositalari, tibbiy buyumlar va tibbiy texnikaning roʻyxatdan oʻtkazish hujjatlarining maʼmuriy, kimyoviy, farmatsevtik, biologik va texnik qismlarini ekspertizadan oʻtkazadi;</a></div><div class="COMMENT"><label id="s3934"></label><a id="edi-5384473"><a href="/acts/-3594817?ONDATE=26.03.2018 00#-3596148">Oldingi</a> tahrirga qarang.</a></div><div class="BY_DEFAULT"><a id="-5384473"></a></div><div class="ACT_TEXT"><a id="-5384475">normativ hujjatlarni baholaydi, dori vositalari (Jahon sogʻliqni saqlash tashkiloti tomonidan qayta malakalangan dori preparatlari va “in vitro” tashxis tibbiy buyumlari bundan mustasno), tibbiy buyumlar va tibbiy texnika namunalarining normativ hujjatlar talablariga muvofiqligini aniqlash boʻyicha sinovlar oʻtkazadi;</a></div><div class="CHANGES_ORIGINS"><label id="s1104"></label><a id="-5384478">(19-band “b” kichik bandining uchinchi xatboshisi Oʻzbekiston Respublikasi Vazirlar Mahkamasining 2019-yil 17-avgustdagi 678-sonli <a href="/acts/-4477408?ONDATE=17.08.2019 00#-4480982">qarori </a>tahririda — Qonun hujjatlari maʼlumotlari milliy bazasi, 17.08.2019-y., 09/19/678/3577-son)</a></div><div class="ACT_TEXT"><a id="-3596149">sinovlar bayonnomalarini, roʻyxatdan oʻtkazish hujjatlarini Farmakopeya, Farmakologiya va Yangi tibbiy texnika qoʻmitalariga taqdim etadi.</a></div><div class="ACT_TEXT"><a id="-3596151">v) Farmakopeya qoʻmitasi:</a></div><div class="COMMENT"><label id="s3934"></label><a id="edi-7093115"><a href="/acts/-3594817?ONDATE=26.03.2018 00#-3596152">Oldingi</a> tahrirga qarang.</a></div><div class="BY_DEFAULT"><a id="-7093115"></a></div><div class="ACT_TEXT"><a id="-7093116">dori vositalari roʻyxatdan oʻtkazish hujjatlarining maʼmuriy, kimyoviy, farmatsevtik va biologik qismlarini, laboratoriya sinovlari bayonnomalarini ekspertizadan oʻtkazadi hamda dori vositalarida IMOga boʻlgan huquqlarga rioya etilganligini tekshiradi;</a></div><div class="CHANGES_ORIGINS"><label id="s1104"></label><a id="-7093119">(19-band “v” kichik bandining ikkinchi xatboshisi Oʻzbekiston Respublikasi Vazirlar Mahkamasining 2024-yil 31-avgustdagi 535-sonli <a href="/acts/-7090221?ONDATE=04.09.2024 00#-7090668">qarori </a>tahririda — Qonunchilik maʼlumotlari milliy bazasi, 04.09.2024-y., 09/24/535/0679-son)</a></div><div class="ACT_TEXT"><a id="-3596154">milliy va xalqaro standartlar talablari bilan muvofiqlashtirish maqsadida ariza beruvchidan normativ hujjatlarga muqobil usullarni va (yoki) qoʻshimcha koʻrsatkichlar, normalar va sinov usullarini kiritishni talab qiladi;</a></div><div class="ACT_TEXT"><a id="-3596155">mustaqil ekspertlarni jalb etgan holda dori vositalari va (yoki) farmakologik vositalarning hujjatlarini ekspertizadan va takroriy ekspertizadan oʻtkazadi;</a></div><div class="ACT_TEXT" style="color:#808080;"><a id="-3596156">qoʻshimcha sinovlar oʻtkazish uchun Davlat markazining laboratoriyalariga dori vositasining namunalari va hujjatlarini yuboradi;</a></div><div class="COMMENT"><label id="s3935"></label><a id="edi-3596156"><a href="/acts/-3594817?ONDATE=15.02.2025 00#edi-7404120">Keyingi</a> tahrirga qarang.</a></div><div class="ACT_TEXT"><a id="-3596157">dori vositalari va tibbiy buyumlarning normativ hujjatlarini tasdiqlaydi;</a></div><div class="COMMENT"><label id="s3934"></label><a id="edi-7093120"><a href="/acts/-3594817?ONDATE=26.03.2018 00#-3596158">Oldingi</a> tahrirga qarang.</a></div><div class="BY_DEFAULT"><a id="-7093120"></a></div><div class="ACT_TEXT"><a id="-7093121">taqdim etilgan hujjatlar, ekspertlar xulosalari hamda dori vositalarida IMOga boʻlgan huquqlarga rioya etilganligi yuzasidan tekshirishlarning natijalari asosida dori vositalarini roʻyxatdan oʻtkazish yoki roʻyxatdan oʻtkazishni rad etish toʻgʻrisidagi tavsiyalarni belgilangan tartibda Oʻzbekiston Respublikasi Sogʻliqni saqlash vazirligi tomonidan tashkil etilgan Ekspertlar kengashiga (keyingi oʻrinlarda Ekspertlar kengashi deb ataladi) kiritadi.</a></div><div class="CHANGES_ORIGINS"><label id="s1104"></label><a id="-7093122">(19-band “v” kichik bandining yettinchi xatboshisi Oʻzbekiston Respublikasi Vazirlar Mahkamasining 2024-yil 31-avgustdagi 535-sonli <a href="/acts/-7090221?ONDATE=04.09.2024 00#-7090668">qarori </a>tahririda — Qonunchilik maʼlumotlari milliy bazasi, 04.09.2024-y., 09/24/535/0679-son)</a></div><div class="ACT_TEXT"><a id="-3596160">g) Farmakologiya qoʻmitasi:</a></div><div class="ACT_TEXT"><a id="-3596166">farmakologik va (yoki) dori vositalarini roʻyxatdan oʻtkazish hujjatlarining maʼmuriy, farmakologik, toksikologik va klinik qismlarini ekspertizadan oʻtkazadi;</a></div><div class="ACT_TEXT"><a id="-3596167">mustaqil ekspertlarni jalb etgan holda farmakologik va (yoki) dori vositalarining hujjatlarini ekspertizadan oʻtkazadi;</a></div><div class="BY_DEFAULT"><a id="-3596168"></a></div><div class="COMMENT"><label id="s3934"></label><a id="edi-5384550"><a href="/acts/-3594817?ONDATE=26.03.2018 00#-5384549">Oldingi</a> tahrirga qarang.</a></div><div class="BY_DEFAULT"><a id="-5384550"></a></div><div class="ACT_TEXT"><a id="-5384551">quyidagi xollarda dori vositasini klinik tadqiqotlarsiz qoʻllash mumkinligi toʻgʻrisidagi tavsiyalarni Ekspertlar kengashiga kiritadi:</a></div><div class="CHANGES_ORIGINS"><label id="s1104"></label><a id="-5384554">(19-band “g” kichik bandining toʻrtinchi xatboshisi Oʻzbekiston Respublikasi Vazirlar Mahkamasining 2019-yil 17-avgustdagi 678-sonli <a href="/acts/-4477408?ONDATE=17.08.2019 00#-4480987">qarori </a>tahririda — Qonun hujjatlari maʼlumotlari milliy bazasi, 17.08.2019-y., 09/19/678/3577-son)</a></div><div class="COMMENT"><label id="s3934"></label><a id="edi-6270097"><a href="/acts/-3594817?ONDATE=26.03.2018 00#-3596169">Oldingi</a> tahrirga qarang.</a></div><div class="BY_DEFAULT"><a id="-6270097"></a></div><div class="ACT_TEXT"><a id="-6270098">dori vositalarini roʻyxatdan oʻtkazish natijalari Oʻzbekiston Respublikasida tan olinadigan mamlakatlar, xalqaro va xorijiy tashkilotlarda roʻyxatdan oʻtkazilgan dori vositalari taqdim etilganda;</a></div><div class="CHANGES_ORIGINS"><label id="s1104"></label><a id="-6270099">(19-band “g” kichik bandining beshinchi xatboshisi Oʻzbekiston Respublikasi Prezidentining 2022-yil 26-oktabrdagi PQ-411-sonli <a href="/acts/-6252758?ONDATE=27.10.2022 00#-6254157">qarori</a> tahririda — Qonunchilik maʼlumotlari milliy bazasi, 27.10.2022-y., 07/22/411/0961-son)</a></div><div class="COMMENT"><label id="s3934"></label><a id="edi-5384563"><a href="/acts/-3594817?ONDATE=26.03.2018 00#-3596170">Oldingi</a> tahrirga qarang.</a></div><div class="BY_DEFAULT"><a id="-5384563"></a></div><div class="ACT_TEXT"><a id="-5384566">dori vositasining GMP (zarur tarzda ishlab chiqarish amaliyoti) talablariga muvofiq ishlab chiqarilganligi va klinik tadqiqotlarning GCP (zarur tarzdagi klinika amaliyoti) talablariga muvofiq oʻtkazilganligi, farmakologik nazorat tizimining GVP (farmakologik nazorat amaliyoti) yoʻlga qoʻyilganligi, shuningdek — Jahon sogʻliqni saqlash tashkiloti tomonidan qayta malakalanganligi toʻgʻrisidagi tasdiqlangan hujjatlar mavjud boʻlgan taqdirda;</a></div><div class="CHANGES_ORIGINS"><label id="s1104"></label><a id="-5384570">(19-band “g” kichik bandining oltinchi xatboshisi Oʻzbekiston Respublikasi Vazirlar Mahkamasining 2019-yil 17-avgustdagi 678-sonli <a href="/acts/-4477408?ONDATE=17.08.2019 00#-4480990">qarori</a> tahririda — Qonun hujjatlari maʼlumotlari milliy bazasi, 17.08.2019-y., 09/19/678/3577-son)</a></div><div class="COMMENT"><label id="s3934"></label><a id="edi-6270102"><a href="/acts/-3594817?ONDATE=26.03.2018 00#-6270100">Oldingi</a> tahrirga qarang.</a></div><div class="BY_DEFAULT"><a id="-6270102"></a></div><div class="ACT_TEXT"><a id="-6270103">Oʻzbekiston Respublikasi Prezidentining 2018-yil 24-sentabrdagi PQ-3948-son qarori bilan tasdiqlangan Dori vositalarini roʻyxatdan oʻtkazish natijalari Oʻzbekiston Respublikasida tan olinadigan mamlakatlar, xalqaro va xorijiy tashkilotlar <a href="/acts/-3914460#-3921455">roʻyxatida</a> keltirilgan mamlakat va tashkilotlar nazorati ostida oʻtkazilgan klinik tadqiqotlarning ijobiy xulosasi mavjud boʻlganda;</a></div><div class="ACT_TEXT"><a id="-6270104">alohida dori vositalarini klinik tadqiqotlarsiz davlat roʻyxatidan oʻtkazish Sogʻliqni saqlash vazirligi tomonidan belgilangan tartibga muvofiq amalga oshiriladi;</a></div><div class="CHANGES_ORIGINS"><label id="s1104"></label><a id="-6270105">(19-bandning “g” kichik bandi Oʻzbekiston Respublikasi Prezidentining 2022-yil 26-oktabrdagi PQ-411-sonli <a href="/acts/-6252758?ONDATE=27.10.2022 00#-6254165">qaroriga</a> asosan yettinchi va sakkizinchi xatboshilar bilan toʻldirilgan — Qonunchilik maʼlumotlari milliy bazasi, 27.10.2022-y., 07/22/411/0961-son)</a></div><div class="COMMENT"><label id="s527"></label><div class="COMMENTLEXUZ"><img src="/image/favicon.gif"> LexUZ sharhi</img></div></div><div class="COMMENT"><label id="s527"></label><a id="-7212769"><em>Qarang: Oʻzbekiston Respublikasi Prezidentining 2022-yil 26-oktabrdagi PQ-411-sonli “Aholini sifatli dori vositalari va tibbiy buyumlar bilan taʼminlash yuzasidan qoʻshimcha chora-tadbirlar toʻgʻrisida”gi </em><a href="/acts/-6252758">qarori</a><em>.</em></a></div><div class="COMMENT"><label id="s3934"></label><a id="edi-5384574"><a href="/acts/-3594817?ONDATE=26.03.2018 00#-3596171">Oldingi</a> tahrirga qarang.</a></div><div class="BY_DEFAULT"><a id="-5384574"></a></div><div class="ACT_TEXT"><a id="-5384575">farmakologik yoki dori vositalarining odamda klinik tadqiqotlarini oʻtkazish toʻgʻrisidagi tavsiyalarni Ekspertlar kengashiga kiritadi;</a></div><div class="CHANGES_ORIGINS"><label id="s1104"></label><a id="-5384576">(19-band “g” kichik bandining beshinchi xatboshisi Oʻzbekiston Respublikasi Vazirlar Mahkamasining 2019-yil 17-avgustdagi 678-sonli <a href="/acts/-4477408?ONDATE=17.08.2019 00#-4480992">qarori </a>tahririda — Qonun hujjatlari maʼlumotlari milliy bazasi, 17.08.2019-y., 09/19/678/3577-son)</a></div><div class="ACT_TEXT"><a id="-3596172">tadqiqotlar turlarini belgilaydi, klinik tadqiqotlar oʻtkazish uchun klinik bazalarni maʼqullaydi, klinik tadqiqotlar dasturlari va bayonnomalarini ishlab chiqish boʻyicha tavsiyalar beradi va ularni maʼqullaydi;</a></div><div class="ACT_TEXT"><a id="-3596173">taqdim etilgan hujjatlar va ekspertlarning xulosalari asosida Ekspertlar kengashiga klinik tadqiqotlarsiz yoki klinik tadqiqotlar asosida dori vositalarini roʻyxatdan oʻtkazish yoki roʻyxatdan oʻtkazishni rad etish toʻgʻrisidagi tavsiyalarni koʻrib chiqish uchun kiritadi;</a></div><div class="ACT_TEXT"><a id="-3596174">dori vositalarini tibbiyotda qoʻllash boʻyicha yoʻriqnomalarni yoki ularga kiritiladigan oʻzgartirishlarni kelishadi va tasdiqlaydi;</a></div><div class="ACT_TEXT"><a id="-3596175">farmokologik nazorat boʻyicha faoliyatni amalga oshiradi; </a></div><div class="ACT_TEXT"><a id="-3596176">d) Yangi tibbiy texnika qoʻmitasi:</a></div><div class="ACT_TEXT"><a id="-3596177">tibbiy buyumlar va tibbiy texnikaning roʻyxatdan oʻtkazish hujjatlarining maʼmuriy, kimyoviy, biologik, texnik qismlarini, laboratoriya sinovlari bayonnomalarini, shuningdek, klinik tadqiqotlar materiallarini ekspertizadan oʻtkazadi;</a></div><div class="ACT_TEXT"><a id="-3596179">mustaqil ekspertlarni jalb etgan holda tibbiy buyumlarning roʻyxatdan oʻtkazish hujjatlarini ekspertizadan va takroriy ekspertizadan oʻtkazadi;</a></div><div class="ACT_TEXT"><a id="-3596180">tibbiy buyumlar va tibbiy texnikaning oʻziga xos xususiyatlaridan kelib chiqqan holda akkreditatsiyadan oʻtgan laboratoriyalarda yoki tibbiy buyumlar va tibbiy texnika oʻrnatilgan joyda sinovlarning amalga oshirilishini taʼminlaydi;</a></div><div class="ACT_TEXT"><a id="-3596182">klinik tadqiqotlarning dasturlarini ishlab chiqish boʻyicha tavsiyalar beradi va klinik tadqiqotlar dasturlarini kelishadi;</a></div><div class="ACT_TEXT"><a id="-3596183">tadqiqotlar turlarini belgilaydi, tibbiy buyumlar va tibbiy texnikaning klinik tadqiqotlarini oʻtkazish uchun klinik bazalarni (davolash-profilaktika muassasalarini) maʼqullaydi;</a></div><div class="ACT_TEXT"><a id="-3596185">mahalliy ishlab chiqaruvchilar tibbiy buyumlarining va tibbiy texnikasining qoʻllash (ekspluatatsiya qilish) boʻyicha yoʻriqnomalarini va markirovkasini yoki ularga kiritiladigan oʻzgartirish yoki qoʻshimchalarni kelishadi;</a></div><div class="ACT_TEXT"><a id="-3596186">tibbiy buyumlar va tibbiy texnikaning normativ hujjatlarini kelishishga yoki tasdiqlashga tayyorlaydi;</a></div><div class="ACT_TEXT"><a id="-3596188">taqdim etilgan hujjatlar va ekspertlarning xulosalari asosida Ekspertlar kengashiga tibbiy buyumlar va tibbiy texnikani klinik sinovlarsiz yoki klinik tadqiqotlar asosida roʻyxatdan oʻtkazish yoki roʻyxatdan oʻtkazishni rad etish haqida tavsiyalarni koʻrib chiqish uchun kiritadi;</a></div><div class="ACT_TEXT"><a id="-3596190">e) Narkotiklarni nazorat qilish qoʻmitasi:</a></div><div class="ACT_TEXT"><a id="-3596192">tarkibida giyohvand vositalar, psixotrop moddalar va prekursorlar mavjud boʻlgan dori vositalarining roʻyxat oʻtkazish hujjatlarini ekspertizadan oʻtkazadi;</a></div><div class="ACT_TEXT"><a id="-3596193">tarkibida giyohvand vositalar, psixotrop moddalar va prekursorlar mavjud boʻlgan dori vositalarini ekspertizadan oʻtkazishda davlat nazoratida boʻlgan giyohvand vositalar, psixotrop moddalar va prekursorlar roʻyxatida ushbu moddalarning mavjudligini, ularni tibbiyotda qoʻllashga ruxsatnomalarni, shuningdek, ularni vrach retsepti boʻyicha berish zarurligini koʻrib chiqadi hamda Farmakologiya va Farmakopeya qoʻmitalariga takliflar kiritadi;</a></div><div class="ACT_TEXT"><a id="-3596194">j) Farminspeksiya:</a></div><div class="ACT_TEXT"><a id="-3596196">yangi dori shakli yoki tibbiy buyum turini ishlab chiqarish, sifatini nazorat qilish tashkil etilgan taqdirda dori vositalari va tibbiy buyumlar ishlab chiqarish korxonalarida ishlab chiqarish va sifatni nazorat qilish sharoitlarining ishlab chiqarishni tashkil etish hamda sifatni nazorat qilish qoidalariga muvofiqligini tekshiradi;</a></div><div class="ACT_TEXT"><a id="-3596197">tekshirish natijalariga koʻra dori vositasi, tibbiy buyumlar tegishli turini ishlab chiqarish va sifatini nazorat qilish sharoitlarining mavjudligi toʻgʻrisida maʼlumotnoma beradi;</a></div><div class="COMMENT"><label id="s3934"></label><a id="edi-6270112"><a href="/acts/-3594817?ONDATE=26.03.2018 00#-3596198">Oldingi</a> tahrirga qarang.</a></div><div class="BY_DEFAULT"><a id="-6270112"></a></div><div class="ACT_TEXT"><a id="-6270114">z) “Zarur amaliyotlar markazi” davlat unitar korxonasi:</a></div><div class="ACT_TEXT"><a id="-6270115">dori vositalari ishlab chiqaruvchi korxonalarda joyiga chiqqan holda, joyiga chiqishning imkoni boʻlmagan taqdirda masofadan (onlayn) dori vositasini ishlab chiqarish sharoitlarining “Zarur ishlab chiqarish amaliyoti (GMP)” talablariga muvofiqligi yuzasidan farmatsevtik inspeksiyalarni olib boradi;</a></div><div class="ACT_TEXT"><a id="-6270116">roʻyxatdan oʻtkazish uchun taqdim etilgan dori vositalarini ishlab chiqarish maydonining “Zarur ishlab chiqarish amaliyoti (GMP)” Oʻzbekiston Respublikasi davlat standarti talablariga muvofiqligi yuzasidan farmatsevtik inspeksiya oʻtkazish maqsadida hujjatlashtirilgan standart operatsion jarayonlar va sifat menejmenti tizimi jarayonlari roʻyxati hamda ishlab chiqarish maydonining asosiy hujjatlari (sayt master-fayl, yozma va chizma qismlarini) nusxalarini “Zarur amaliyotlar markazi” davlat unitar korxonasiga taqdim etish toʻgʻrisida ariza beruvchiga xabarnoma yuboradi;</a></div><div class="ACT_TEXT"><a id="-6270117">yuborilgan xabarnoma boʻyicha taqdim etilgan hujjatlar toʻliqligi yuzasidan ekspertiza oʻtkazadi hamda ariza beruvchi bilan farmatsevtik inspeksiya oʻtkazish boʻyicha shartnoma tuzadi;</a></div><div class="ACT_TEXT"><a id="-6270118">farmatsevtik inspeksiya oʻtkazish uchun toʻlov amalga oshirilgandan soʻng, ariza beruvchi bilan farmatsevtik inspeksiya oʻtkazish muddatlarini kelishish uchun unga inspeksiya dasturini yoʻllaydi;</a></div><div class="ACT_TEXT"><a id="-6270119">farmatsevtik inspeksiyani bevosita ishlab chiqarish maydonida oʻtkazadi hamda natijalari boʻyicha hisobot tuzadi;</a></div><div class="ACT_TEXT"><a id="-6270120">farmatsevtik inspeksiya jarayonida nomuvofiqliklar aniqlangan taqdirda, ularni bartaraf etish uchun oʻrnatilgan tartibda muddatlarni belgilaydi hamda ushbu belgilangan muddatlarda nomuvofiqliklar amalda bartaraf etilganligi holatini zaruratga koʻra joyiga chiqqan holda oʻrganadi.</a></div><div class="ACT_TEXT"><a id="-6270121">“Zarur amaliyotlar markazi” davlat unitar korxonasi tomonidan farmatsevtik inspeksiya natijalari boʻyicha ijobiy hisobot tuzilgan taqdirda, ishlab chiqaruvchiga amal qilish muddati uch yil boʻlgan sertifikat taqdim etiladi.</a></div><div class="ACT_TEXT"><a id="-6270122">Sertifikat taqdim etilgandan soʻng ariza beruvchi ishlab chiqarish maydoni menejment tizimiga taʼsir qilishi mumkin boʻlgan har qanday oʻzgarishlar haqida “Zarur amaliyotlar markazi” davlat unitar korxonasiga oʻz vaqtida xabar berishi lozim.</a></div><div class="ACT_TEXT"><a id="-6270123">“Zarur amaliyotlar markazi” davlat unitar korxonasi “Zarur ishlab chiqarish amaliyoti (GMP)” talablariga muvofiqlik yuzasidan oʻtkazilgan farmatsevtik inspeksiya natijalariga asosan dori vositalarini roʻyxatdan oʻtkazish yoki roʻyxatdan oʻtkazishni rad etish toʻgʻrisidagi xulosalarni Ekspertlar kengashiga belgilangan tartibda taqdim etadi.</a></div><div class="BY_DEFAULT"><a id="-6270124"></a></div><div class="ACT_TEXT" style="color:#808080;"><a id="-7404139">“Zarur amaliyotlar markazi” davlat unitar korxonasi quyidagi hollarda Davlat markaziga dori vositalarini roʻyxatdan oʻtkazishni rad etish boʻyicha Davlat markaziga tavsiya berishi mumkin:</a></div><div class="COMMENT"><label id="s3935"></label><a id="edi-7404139"><a href="/acts/-3594817?ONDATE=15.02.2025 00#edi-7404140">Keyingi</a> tahrirga qarang.</a></div><div class="ACT_TEXT"><a id="-6270125">ariza beruvchi farmatsevtik inspeksiyaning bevosita ishlab chiqarish maydonida oʻtkazilishidan bosh tortganda;</a></div><div class="ACT_TEXT"><a id="-6270126">farmatsevtik inspeksiya oʻtkazish uchun talab qilingan maʼlumotlar, hujjatlar oʻrganish uchun soʻrab olinganda taqdim etilmaganda, bino va xonalarga inspektorlar kirishiga yoʻl qoʻyilmaganda;</a></div><div class="ACT_TEXT"><a id="-6270127">farmatsevtik inspeksiya mobaynida qalbaki hujjatlar va maʼlumotlar taqdim etilgani aniqlanganda;</a></div><div class="ACT_TEXT"><a id="-6270128">farmatsevtik inspeksiya natijalari boʻyicha aniqlangan nomuvofiqliklar ishlab chiqaruvchi korxona bilan kelishilgan muddatlarda toʻgʻri va toʻliq bartaraf etilmaganda.</a></div><div class="ACT_TEXT"><a id="-6270129">Farmatsevtik inspeksiyalarni oʻtkazish bilan bogʻliq xarajatlarga toʻlangan haq oʻtkazilgan farmatsevtik inspeksiya natijalaridan qatʼi nazar, ariza beruvchiga qaytarilmaydi.</a></div><div class="ACT_TEXT"><a id="-6270130">Dori vositasini ishlab chiqaruvchi farmatsevtik inspeksiya oʻtkazish maqsadida “Zarur amaliyotlar markazi” davlat unitar korxonasiga dori vositasini Oʻzbekiston Respublikasida davlat roʻyxatidan oʻtkazish jarayonidan tashqari holda (davlat roʻyxatidan oʻtkazish jarayoni bilan bogʻliq boʻlmagan holatlarda) ham murojaat qilishi mumkin.</a></div><div class="ACT_TEXT"><a id="-6270131">Inspeksiya oʻtkazilgan ishlab chiqarish maydoni GMP talablariga nomuvofiq ekanligi aniqlansa, ushbu ishlab chiqarish maydonida ilgari ishlab chiqarilgan va davlat roʻyxatidan oʻtkazilgan, muomaladagi dori vositalarini roʻyxatdan oʻtkazilganlik guvohnomasining amal qilishini toʻxtatib turish boʻyicha Ekspertlar kengashiga tavsiya beriladi.</a></div><div class="ACT_TEXT"><a id="-6270132">Roʻyxatdan oʻtkazilganlik guvohnomasining amal qilishini qayta tiklash, oʻtkazilgan farmatsevtik inspeksiya mobaynida aniqlangan barcha nomuvofiqliklar toʻliq bartaraf etilganidan soʻng, qayta farmatsevtik inspeksiya oʻtkazilib ijobiy natijalar qayd etilgan taqdirda amalga oshiriladi.</a></div><div class="CHANGES_ORIGINS"><label id="s1104"></label><a id="-6270133">(19-bandning “z” kichik bandi Oʻzbekiston Respublikasi Prezidentining 2022-yil 26-oktabrdagi PQ-411-sonli <a href="/acts/-6252758?ONDATE=27.10.2022 00#-6254180">qarori</a> tahririda — Qonunchilik maʼlumotlari milliy bazasi, 27.10.2022-y., 07/22/411/0961-son)</a></div><div class="ACT_TEXT" style="color:#808080;"><a id="-3596201">20. Ekspertlar kengashi Farmakopeya, Farmakologiya, Yangi tibbiy texnika qoʻmitalari, shuningdek Davlat markazining boshqa boʻlinmalari xulosalari asosida dori vositalari, tibbiy buyumlar va tibbiy texnikaning tibbiyot amaliyotida qoʻllanilishiga ruxsat berish yoki ruxsat berishni rad etish toʻgʻrisida qaror qabul qiladi.</a></div><div class="COMMENT"><label id="s3935"></label><a id="edi-3596201"><a href="/acts/-3594817?ONDATE=15.02.2025 00#edi-7404143">Keyingi</a> tahrirga qarang.</a></div><div class="BY_DEFAULT"><a id="-3596203"></a></div><div class="ACT_TEXT" style="color:#808080;"><a id="-7404146">21. Davlat markazi Ekspertlar kengashi tomonidan qaror qabul qilingan kundan bir ish kunidan kechikmay ariza beruvchiga ushbu Nizomning 4-(dori vositalari uchun) va 4a-(tibbiy buyumlar va tibbiy texnika uchun) ilovalariga<a href="/acts/-3594817#-3597452">*</a> muvofiq shakldagi guvohnomani beradi (yoki yuboradi) yoki uni yozma shaklda, jumladan, axborot tizimi orqali elektron shaklda guvohnoma berish rad etilganligi toʻgʻrisida xabardor qiladi.</a></div><div class="COMMENT"><label id="s3935"></label><a id="edi-7404146"><a href="/acts/-3594817?ONDATE=15.02.2025 00#edi-7404147">Keyingi</a> tahrirga qarang.</a></div><div class="FOOTNOTE"><a id="-3597452">* <a href="/acts/3594815#3596850">2 — 4a-ilovalar </a>rus tilidagi matnda berilgan.</a></div><div class="ACT_TEXT"><a id="-3596206">22. Quyidagilar guvohnoma berishni rad etish uchun asos boʻlishi mumkin:</a></div><div class="ACT_TEXT"><a id="-3596208">guvohnoma berish uchun zarur boʻlgan hujjatlarning, dori vositalari va tibbiy buyumlar va tibbiy texnika namunalarining va boshqa talab qilinadigan materiallarning ariza beruvchi tomonidan toʻliq boʻlmagan hajmda taqdim etilishi;</a></div><div class="ACT_TEXT"><a id="-3596209">ariza beruvchining ruxsat berish talablari va shartlariga nomuvofiqligi;</a></div><div class="ACT_TEXT"><a id="-3596210">ariza beruvchi tomonidan taqdim etilgan hujjatlarda ishonchsiz yoki buzib koʻrsatilgan maʼlumotlarning mavjudligi; </a></div><div class="ACT_TEXT"><a id="-3596211">dori vositalari, tibbiy buyumlar va tibbiy texnikaning sifati, xavfsizligi va samaradorligini tavsiflovchi laboratoriya sinovlari, klinik tadqiqotlar, ishlab chiqarishni tekshirish yoki boshqa ilmiy-texnik baholash (dori vositalari va tibbiy buyumlar va tibbiy texnikaning roʻyxatdan oʻtkazish hujjatlarini ekspertizadan oʻtkazish) yakunlari boʻyicha asoslangan salbiy xulosalarning olinishi.</a></div><div class="COMMENT"><label id="s3934"></label><a id="edi-5995168"><a href="/acts/-3594817?ONDATE=26.03.2018 00#-5995166">Oldingi</a> tahrirga qarang.</a></div><div class="BY_DEFAULT"><a id="-5995168"></a></div><div class="ACT_TEXT"><a id="-5995172">dori vositalari, tibbiy buyumlar va tibbiy texnikalarga nisbatan intellektual mulk obyektlariga boʻlgan huquqlarning buzilganligi; </a></div><div class="CHANGES_ORIGINS"><label id="s1104"></label><a id="-5995195">(22-band Oʻzbekiston Respublikasi Prezidentining 2022-yil 26-apreldagi PQ-221-sonli <a href="/acts/-5987120?ONDATE=26.04.2022 00#-5988245">qaroriga</a> asosan oltinchi xatboshi bilan toʻldirilgan — Qonunchilik maʼlumotlari milliy bazasi, 26.04.2022-y., 07/22/221/0357-son)</a></div><div class="ACT_TEXT"><a id="-3596212">Guvohnoma berishning boshqa asoslarga koʻra, shu jumladan, maqsadga muvofiq emasligi sabablari boʻyicha rad etilishiga yoʻl qoʻyilmaydi.</a></div><div class="COMMENT"><label id="s3934"></label><a id="edi-5995127"><a href="/acts/-3594817?ONDATE=26.03.2018 00#-3596213">Oldingi</a> tahrirga qarang.</a></div><div class="BY_DEFAULT"><a id="-5995127"></a></div><div class="ACT_TEXT"><a id="-5995131">23. Guvohnomani berishning rad etilganligi toʻgʻrisidagi xabarnoma ariza beruvchiga yozma shaklda, shuningdek, axborot tizimi orqali elektron shaklda, rad etishning sabablari, qonunchilikning aniq normalari hamda ariza beruvchi koʻrsatilgan sabablarni bartaraf etib, hujjatlarni takroran koʻrib chiqish uchun taqdim etishi mumkin boʻlgan muddat koʻrsatilgan holda yuboriladi (topshiriladi). Ariza beruvchi rad etish sabablarini bartaraf etishga va takroriy koʻrib chiqish uchun hujjatlarni taqdim etishga haqli boʻlgan muddat guvohnoma berishni rad etish toʻgʻrisidagi xabarnoma olingan kundan boshlab 10 ish kunidan kam boʻlishi mumkin emas.</a></div><div class="CHANGES_ORIGINS"><label id="s1104"></label><a id="-5995153">(23-band Oʻzbekiston Respublikasi Vazirlar Mahkamasining 2022-yil 4-apreldagi 153-sonli <a href="/acts/-5936929?ONDATE=05.04.2022 00#-5939320">qarori</a> tahririda — Qonunchilik maʼlumotlari milliy bazasi, 05.04.2022-y., 09/22/153/0266-son)</a></div><div class="BY_DEFAULT"><a id="-3596214"></a></div><div class="ACT_TEXT" style="color:#808080;"><a id="-7404150">24. Guvohnoma berish uchun asos boʻlgan sabablar belgilangan muddatda ariza beruvchi tomonidan bartaraf etilgan taqdirda, hujjatlarni takroran koʻrib chiqish va ekspertiza jarayonini davom ettirish Davlat markazi tomonidan ariza beruvchining rad etish sabablari bartaraf etilganligi toʻgʻrisidagi arizasi hamda rad etish sabablari bartaraf etilganligini tasdiqlovchi tegishli hujjatlar olingan kundan boshlab 10 ish kunidan oshmaydigan muddatda amalga oshiriladi, ushbu bandning <a href="/acts/-3594817#-3596262">uchinchi xatboshida </a>nazarda tutilgan holatlar bundan mustasno.</a></div><div class="COMMENT"><label id="s3935"></label><a id="edi-7404150"><a href="/acts/-3594817?ONDATE=15.02.2025 00#edi-7404151">Keyingi</a> tahrirga qarang.</a></div><div class="ACT_TEXT"><a id="-3596261">Arizaning takroran koʻrib chiqilganligi uchun yigʻim undirilmaydi.</a></div><div class="ACT_TEXT" style="color:#808080;"><a id="-3596262">Agar rad etish sabablarining ariza beruvchi tomonidan bartaraf etilishi dori vositalari va tibbiy buyumlar va tibbiy texnikaning sifati, samaradorligi va xavfsizligi xossalarining oʻzgarishiga olib kelsa, u holda ariza yangidan berilgan hisoblanadi va Davlat markazi tomonidan umumiy asoslarda koʻrib chiqiladi.</a></div><div class="COMMENT"><label id="s3935"></label><a id="edi-3596262"><a href="/acts/-3594817?ONDATE=15.02.2025 00#edi-7404159">Keyingi</a> tahrirga qarang.</a></div><div class="ACT_TEXT" style="color:#808080;"><a id="-3596263">25. Hujjatlarni takroran koʻrib chiqishda Davlat markazi tomonidan ilgari ariza beruvchiga yozma shaklda yoki axborot tizimi orqali elektron shaklda bayon qilinmagan sabablarning keltirilishiga yoʻl qoʻyilmaydi, ilgari koʻrsatilgan sabablarning bartaraf etilganligini tasdiqlovchi hujjatlar bilan bogʻliq boʻlgan rad etish sabablarining keltirilishi bundan mustasno.</a></div><div class="COMMENT"><label id="s3935"></label><a id="edi-3596263"><a href="/acts/-3594817?ONDATE=15.02.2025 00#edi-7404171">Keyingi</a> tahrirga qarang.</a></div><div class="ACT_TEXT" style="color:#808080;"><a id="-3596264">26. Guvohnoma berishning rad etilgani toʻgʻrisidagi xabarnomada koʻrsatilgan muddat oʻtgandan keyin ariza beruvchi tomonidan berilgan ariza yangidan berilgan hisoblanadi va Davlat markazi tomonidan umumiy asoslarda koʻrib chiqiladi.</a></div><div class="COMMENT"><label id="s3935"></label><a id="edi-3596264"><a href="/acts/-3594817?ONDATE=15.02.2025 00#edi-7404185">Keyingi</a> tahrirga qarang.</a></div><div class="ACT_TEXT" style="color:#808080;"><a id="-3596267">27. Ariza beruvchi guvohnoma berishning rad etilishi, shuningdek Davlat markazi mansabdor shaxsining harakati (harakatsizligi) yuzasidan belgilangan tartibda shikoyat qilish huquqiga ega.</a></div><div class="COMMENT"><label id="s3935"></label><a id="edi-3596267"><a href="/acts/-3594817?ONDATE=15.02.2025 00#edi-7404195">Keyingi</a> tahrirga qarang.</a></div><div class="ACT_TEXT"><a id="-3596268">28. Guvohnomaning amal qilish muddati oʻtgach dori vositalarini, tibbiy buyumlarni va tibbiy texnikani realizatsiya qilishga hamda tibbiyot amaliyotida qoʻllashga, agar ular roʻyxatdan oʻtkazilganlik guvohnomasining amal qilishi davrida ishlab chiqarilgan boʻlsa, ruxsat etiladi. Bunda dori vositalari, tibbiy buyumlar va tibbiy texnikaning sifat nazoratini guvohnomaning amal qilish muddatida tasdiqlangan normativ hujjatlar talablariga muvofiq oʻtkazilishiga ruxsat beriladi. </a></div><div class="TEXT_HEADER_DEFAULT"><a id="-3596272">5-bob. Roʻyxatdan oʻtkazish hujjatlariga oʻzgartirish va qoʻshimchalar kiritish</a></div><div class="BY_DEFAULT" style="color:#808080;"><a id="-3596273"></a></div><div class="ACT_TEXT" style="color:#808080;"><a id="-7404208">29. Dori vositalari, tibbiy buyumlar va tibbiy texnikaning roʻyxatdan oʻtkazish hujjatlarida keltirilgan maʼlumotlar guvohnomaning amal qilish muddati davomida oʻzgargan taqdirda ariza beruvchi Davlat markaziga oʻzgartirish va qoʻshimchalar kiritish toʻgʻrisidagi ariza bilan tegishli hujjatlar, namunalar va standartlarni (zarur hollarda) ilova qilgan holda murojaat qiladi.</a></div><div class="ACT_TEXT" style="color:#808080;"><a id="-3596275">Oʻzgartirishlar dori vositasi, tibbiy buyum va tibbiy texnikaning sifati, samaradorligi va xavfsizligiga salbiy taʼsir koʻrsatishi mumkin boʻlgan holatlarda Davlat markazi roʻyxatdan oʻtkazish hujjatlariga oʻzgartirish va qoʻshimchalar kiritishni rad etadi.</a></div><div class="COMMENT"><label id="s3935"></label><a id="edi-3596275"><a href="/acts/-3594817?ONDATE=15.02.2025 00#edi-7404209">Keyingi</a> tahrirga qarang.</a></div><div class="BY_DEFAULT"><a id="-3596276"></a></div><div class="ACT_TEXT" style="color:#808080;"><a id="-7404230">30. Ariza beruvchining roʻyxatdan oʻtkazish hujjatlariga oʻzgartirish va qoʻshimchalar kiritish toʻgʻrisidagi arizasi Davlat markazining tegishli boʻlinmalari vakolatlari doirasida quyidagilardan oshmaydigan muddatlarda koʻrib chiqiladi:</a></div><div class="COMMENT"><label id="s3935"></label><a id="edi-7404230"><a href="/acts/-3594817?ONDATE=15.02.2025 00#edi-7404234">Keyingi</a> tahrirga qarang.</a></div><div class="ACT_TEXT"><a id="-3596278">45 kun — dori moddalari (substansiyalar) uchun;</a></div><div class="COMMENT"><label id="s3934"></label><a id="edi-5384579"><a href="/acts/-3594817?ONDATE=26.03.2018 00#-5384578">Oldingi</a> tahrirga qarang.</a></div><div class="BY_DEFAULT"><a id="-5384579"></a></div><div class="ACT_TEXT"><a id="-5384581">30 kun — Jahon sogʻliqni saqlash tashkiloti tomonidan qayta malakalangan dori preparatlari va “in vitro” tashxis tibbiy buyumlari uchun;</a></div><div class="CHANGES_ORIGINS"><label id="s1104"></label><a id="-5384583">(30-band Oʻzbekiston Respublikasi Vazirlar Mahkamasining 2019-yil 17-avgustdagi 678-sonli <a href="/acts/-4477408?ONDATE=17.08.2019 00#-4480994">qaroriga</a> asosan uchinchi xatboshi bilan toʻldirilgan — Qonun hujjatlari maʼlumotlari milliy bazasi, 17.08.2019-y., 09/19/678/3577-son)</a></div><div class="ACT_TEXT"><a id="-3596282">60 kun — qadoqlangan va oʻrash-joylash materialiga joylangan farmakopeya dorivor oʻsimlik xomashyosi shaklidagi dori vositalari, bogʻlov materiallari, teshish, inyeksiya, transfuziya va soʻrib olishga moʻljallangan buyumlar, kontratseptivlar, rezina, rezina mato, lateks, polimerdan tayyorlangan tibbiy buyumlar, bemorlarga birinchi tibbiy yordam koʻrsatish, bemorlarni parvarish qilish uchun tibbiy buyumlar. </a></div><div class="ACT_TEXT"><a id="-3596284">90 kun — qolgan dori vositalari, tibbiy buyumlar va tibbiy texnika uchun.</a></div><div class="ACT_TEXT"><a id="-3596285">Ariza beruvchining roʻyxatdan oʻtkazish hujjatlariga oʻzgartirish va qoʻshimchalar kiritish toʻgʻrisidagi arizasi koʻrib chiqilganligi uchun guvohnoma berish toʻgʻrisidagi ariza koʻrib chiqilganligi uchun toʻlanadigan summaning yarmi miqdorida yigʻim undiriladi.</a></div><div class="ACT_TEXT"><a id="-3596286">31. Roʻyxatdan oʻtkazish hujjatlariga oʻzgartirishlar kiritish guvohnomada keltirilgan maʼlumotlarni oʻzgartirishni talab qilgan taqdirda, roʻyxatdan oʻtkazilganlik guvohnomasiga tegishli oʻzgartirishlar kiritish ham ushbu Nizom 6-bobining <a href="/acts/-3594817#-3596290">32</a>,<a href="/acts/-3594817#-3596294"> 33 </a>va <a href="/acts/-3594817#-3596295">34-bandlariga </a>muvofiq amalga oshiriladi.</a></div><div class="TEXT_HEADER_DEFAULT"><a id="-3596288">6-bob. Guvohnomani qayta rasmiylashtirish, uning amal qilish muddatini uzaytirish, dublikatlar berish</a></div><div class="BY_DEFAULT"><a id="-3596290"></a></div><div class="ACT_TEXT" style="color:#808080;"><a id="-7404246">32. Ariza beruvchi qayta tashkil etilganda, uning nomi yoki joylashgan joyi oʻzgarganda ariza beruvchi yoxud uning huquqiy vorisi qayta roʻyxatdan oʻtkazilgandan keyin yetti ish kuni mobaynida Davlat markaziga guvohnomani qayta rasmiylashtirish toʻgʻrisida, koʻrsatilgan maʼlumotlarni tasdiqlovchi hujjatlarni ilova qilgan holda ariza berishi shart.</a></div><div class="COMMENT"><label id="s3935"></label><a id="edi-7404246"><a href="/acts/-3594817?ONDATE=15.02.2025 00#edi-7404248">Keyingi</a> tahrirga qarang.</a></div><div class="ACT_TEXT" style="color:#808080;"><a id="-3596291">Hujjatlar ariza beruvchi tomonidan Davlat markaziga bevosita yoxud pochta aloqasi vositalari orqali, ularning yetkazib berilganligi yoki elektron shaklda olinganligi toʻgʻrisidagi xabarnoma bilan birga taqdim etiladi. Elektron shaklda taqdim etilgan hujjatlar ariza beruvchining elektron raqamli imzosi bilan tasdiqlanadi.</a></div><div class="COMMENT"><label id="s3935"></label><a id="edi-3596291"><a href="/acts/-3594817?ONDATE=15.02.2025 00#edi-7404253">Keyingi</a> tahrirga qarang.</a></div><div class="ACT_TEXT"><a id="-3596293">Ariza beruvchidan ushbu bandda nazarda tutilmagan hujjatlarning taqdim etilishini talab qilishga yoʻl qoʻyilmaydi.</a></div><div class="ACT_TEXT" style="color:#808080;"><a id="-3596294">33. Guvohnoma qayta rasmiylashtirilgungacha guvohnomani qayta rasmiylashtirish toʻgʻrisida ariza bergan ariza beruvchi yoki uning huquqiy vorisi dori vositasi va tibbiy buyumlar va tibbiy texnikani qoʻllashni guvohnomani qayta rasmiylashtirish toʻgʻrisida berilgan ariza asosida Davlat markazining arizani qabul qilish sanasi toʻgʻrisidagi belgisi bilan amalga oshiriladi.</a></div><div class="COMMENT"><label id="s3935"></label><a id="edi-3596294"><a href="/acts/-3594817?ONDATE=15.02.2025 00#edi-7404259">Keyingi</a> tahrirga qarang.</a></div><div class="BY_DEFAULT" style="color:#808080;"><a id="-3596295"></a></div><div class="ACT_TEXT" style="color:#808080;"><a id="-7404268">34. Guvohnomani qayta rasmiylashtirishda Davlat markazi berilgan guvohnomalar reyestriga tegishli oʻzgartirishlar kiritadi.</a></div><div class="ACT_TEXT" style="color:#808080;"><a id="-3596296">Guvohnomani qayta rasmiylashtirish va berish guvohnomani qayta rasmiylashtirish toʻgʻrisidagi ariza tegishli hujjatlar ilova qilingan holda Davlat markazi tomonidan olingan kundan boshlab 5 ish kunidan koʻp boʻlmagan muddatda amalga oshiriladi.</a></div><div class="COMMENT"><label id="s3935"></label><a id="edi-3596296"><a href="/acts/-3594817?ONDATE=15.02.2025 00#edi-7404269">Keyingi</a> tahrirga qarang.</a></div><div class="ACT_TEXT" style="color:#808080;"><a id="-3596297">35. Guvohnomani qayta rasmiylashtirganlik uchun ariza beruvchining guvohnomani berish toʻgʻrisidagi arizasi Davlat markazi tomonidan koʻrib chiqilganligi uchun toʻlanadigan summaning yarmi miqdorida yigʻim undiriladi. Yigʻim summasi Davlat markazining hisob raqamiga oʻtkaziladi.</a></div><div class="COMMENT"><label id="s3935"></label><a id="edi-3596297"><a href="/acts/-3594817?ONDATE=15.02.2025 00#edi-7404275">Keyingi</a> tahrirga qarang.</a></div><div class="BY_DEFAULT"><a id="-3596299"></a></div><div class="ACT_TEXT" style="color:#808080;"><a id="-7404282">36. Guvohnomaning amal qilish muddati ariza beruvchi tomonidan Davlat markaziga berilgan arizasiga binoan uzaytirilishi mumkin. Guvohnomaning amal qilish muddatini uzaytirish toʻgʻrisidagi ariza Davlat markaziga uning amal qilish muddati tugashidan uch oy oldin berilishi kerak. Guvohnomaning amal qilish muddatini uzaytirish guvohnomani berish uchun nazarda tutilgan tartibda amalga oshiriladi.</a></div><div class="COMMENT"><label id="s3935"></label><a id="edi-7404282"><a href="/acts/-3594817?ONDATE=15.02.2025 00#edi-7404283">Keyingi</a> tahrirga qarang.</a></div><div class="ACT_TEXT" style="color:#808080;"><a id="-3596301">Guvohnomaning amal qilish muddatini uzaytirganlik uchun ariza beruvchining guvohnomani berish toʻgʻrisidagi arizasi koʻrib chiqilganligi uchun toʻlanadigan summaning yarmi miqdorida yigʻim undiriladi. Yigʻim summasi Davlat markazining hisob raqamiga oʻtkaziladi.</a></div><div class="COMMENT"><label id="s3935"></label><a id="edi-3596301"><a href="/acts/-3594817?ONDATE=15.02.2025 00#edi-7404297">Keyingi</a> tahrirga qarang.</a></div><div class="COMMENT"><label id="s3934"></label><a id="edi-6205357"><a href="/acts/-3594817?ONDATE=17.08.2019 00#-5384591">Oldingi</a> tahrirga qarang.</a></div><div class="CHANGES_ORIGINS"><label id="s1104"></label><a id="-6205357">(36-bandning uchinchi xatboshisi Oʻzbekiston Respublikasi Vazirlar Mahkamasining 2022-yil 21-sentabrdagi 519-sonli <a href="/acts/-6201435?ONDATE=21.09.2022 00#-6205111">qaroriga</a> asosan chiqarilgan — Qonunchilik maʼlumotlari milliy bazasi, 21.09.2022-y., 09/22/519/0840-son)</a></div><div class="COMMENT"><label id="s3934"></label><a id="edi-6270135"><a href="/acts/-3594817?ONDATE=26.03.2018 00#-6270134">Oldingi</a> tahrirga qarang.</a></div><div class="BY_DEFAULT"><a id="-6270135"></a></div><div class="ACT_TEXT"><a id="-6270136">Guvohnomaning amal qilish muddatini uzaytirish davrida dori vositasi, tibbiy buyum va tibbiy texnikaning Oʻzbekiston Respublikasida muomalada boʻlishi toʻxtatilmaydi.</a></div><div class="CHANGES_ORIGINS"><label id="s1104"></label><a id="-6270137">(36-band Oʻzbekiston Respublikasi Prezidentining 2022-yil 26-oktabrdagi PQ-411-sonli <a href="/acts/-6252758?ONDATE=27.10.2022 00#-6254227">qaroriga</a> asosan uchinchi xatboshi bilan toʻldirilgan — Qonunchilik maʼlumotlari milliy bazasi, 27.10.2022-y., 07/22/411/0961-son)</a></div><div class="ACT_TEXT"><a id="-3596302">37. Guvohnoma yoʻqolgan yoki yaroqsiz boʻlib qolgan taqdirda ariza beruvchining arizasiga binoan uning dublikati beriladi.</a></div><div class="ACT_TEXT" style="color:#808080;"><a id="-3596303">Davlat markazi guvohnoma dublikatini ariza, shuningdek guvohnoma yaroqsiz holga kelganda uning asl nusxasi hamda guvohnoma dublikati berilganligi uchun ariza beruvchi tomonidan yigʻim toʻlanganligini tasdiqlovchi hujjat olingan kundan boshlab besh ish kunidan koʻp boʻlmagan muddatda berishi (yuborishi) shart.</a></div><div class="COMMENT"><label id="s3935"></label><a id="edi-3596303"><a href="/acts/-3594817?ONDATE=15.02.2025 00#edi-7404305">Keyingi</a> tahrirga qarang.</a></div><div class="COMMENT"><label id="s3934"></label><a id="edi-5708940"><a href="/acts/-3594817?ONDATE=26.03.2018 00#-3596306">Oldingi</a> tahrirga qarang.</a></div><div class="BY_DEFAULT" style="color:#808080;"><a id="-5708940"></a></div><div class="ACT_TEXT" style="color:#808080;"><a id="-5708941">Guvohnomaning dublikati berilganligi uchun Davlat markazi tomonidan bazaviy hisoblash miqdorining 10 foizi miqdorida yigʻim undiriladi. Yigʻim summasi Davlat markazining hisob raqamiga oʻtkaziladi.</a></div><div class="CHANGES_ORIGINS" style="color:#808080;"><label id="s1104"></label><a id="-5708944">(37-bandning uchinchi xatboshisi Oʻzbekiston Respublikasi Vazirlar Mahkamasining 2021-yil 28-oktabrdagi 661-sonli <a href="/acts/-5700620?ONDATE=01.12.2021 00#-5707098">qarori</a> tahririda — Qonunchilik maʼlumotlari milliy bazasi, 29.10.2021-y., 09/21/661/0999-son)</a></div><div class="COMMENT"><label id="s3935"></label><a id="edi-5708944"><a href="/acts/-3594817?ONDATE=15.02.2025 00#edi-7404309">Keyingi</a> tahrirga qarang.</a></div><div class="TEXT_HEADER_DEFAULT"><a id="-3596308">7-bob. Guvohnomaning amal qilishini toʻxtatib turish, toʻxtatish va uni bekor qilish</a></div><div class="ACT_TEXT"><a id="-3596311">38. Guvohnomaning amal qilishini toʻxtatib turish, toʻxtatish va uni bekor qilish “Tadbirkorlik faoliyati sohasidagi ruxsat berish tartib-taomillari toʻgʻrisida”gi Oʻzbekiston Respublikasi Qonunining <a href="/acts/-2103727#-2103855">22</a>,<a href="/acts/-2103727#-2103866"> 23 </a>va <a href="/acts/-2103727#-2103891">25-moddalarida </a>nazarda tutilgan holatlarda va tartibda amalga oshiriladi.</a></div><div class="ACT_TEXT"><a id="-3596314">39. Quyidagilar guvohnomaning amal qilinishini belgilangan tartibda toʻxtatish uchun asos boʻladigan, ruxsat berish talablari va shartlarining bir marotaba qoʻpol ravishda buzilishiga kiradi:</a></div><div class="ACT_TEXT" style="color:#808080;"><a id="-3596316">Davlat markazi tomonidan belgilangan tartibda oʻtkaziladigan ruxsat berish talablari va shartlariga rioya etilishining tekshiruvlaridan bosh tortish;</a></div><div class="COMMENT"><label id="s3935"></label><a id="edi-3596316"><a href="/acts/-3594817?ONDATE=15.02.2025 00#edi-7404324">Keyingi</a> tahrirga qarang.</a></div><div class="ACT_TEXT"><a id="-3596317">berilgan tegishli ruxsat bilan bogʻliq harakatlar va (yoki) muayyan faoliyatni amalga oshirish natijasida fuqarolar hayoti va sogʻligʻiga zarar yetkazish yoxud zarar yetkazilishining real xavfini paydo qilish.</a></div><div class="BY_DEFAULT"><a id="-3596322"></a></div><div class="COMMENT"><label id="s3934"></label><a id="edi-6270141"><a href="/acts/-3594817?ONDATE=26.03.2018 00#-6270140">Oldingi</a> tahrirga qarang.</a></div><div class="BY_DEFAULT"><a id="-6270141"></a></div><div class="TEXT_HEADER_DEFAULT"><a id="-6270142">8-bob. Dori vositalari, tibbiy buyumlar va tibbiy texnika davlat reyestri</a></div><div class="CHANGES_ORIGINS"><label id="s1104"></label><a id="-6270144">(8-bobning nomi Oʻzbekiston Respublikasi Prezidentining 2022-yil 26-oktabrdagi PQ-411-sonli <a href="/acts/-6252758?ONDATE=27.10.2022 00#-6254230">qarori</a> tahririda — Qonunchilik maʼlumotlari milliy bazasi, 27.10.2022-y., 07/22/411/0961-son)</a></div><div class="COMMENT"><label id="s3934"></label><a id="edi-6270146"><a href="/acts/-3594817?ONDATE=26.03.2018 00#-3596324">Oldingi</a> tahrirga qarang.</a></div><div class="BY_DEFAULT"><a id="-6270146"></a></div><div class="BY_DEFAULT"><a id="-6270147"></a></div><div class="ACT_TEXT" style="color:#808080;"><a id="-7404341">40. Davlat markazi Tibbiyot amaliyotida qoʻllanilishiga ruxsat etilgan dori vositalari, tibbiy buyumlar va tibbiy texnika davlat reyestrini yuritadi va uni oʻz rasmiy veb-saytida joylashtiradi.</a></div><div class="COMMENT"><label id="s3935"></label><a id="edi-7404341"><a href="/acts/-3594817?ONDATE=15.02.2025 00#edi-7404343">Keyingi</a> tahrirga qarang.</a></div><div class="ACT_TEXT"><a id="-6270149">Davlat reyestrida quyidagi maʼlumotlar koʻrsatiladi:</a></div><div class="ACT_TEXT"><a id="-6270151">dori vositasining savdo nomi (dorivor oʻsimlik xom ashyosining nomi, dorivor oʻsimlikning binominal ilmiy nomi, oʻsimlik qismlari nomi, boshqa nomlar (boshqa farmakopeyada koʻrsatilgan sinonimlar) bilan beriladi);</a></div><div class="ACT_TEXT"><a id="-6270152">tibbiy buyum va tibbiy texnikaning nomi;</a></div><div class="ACT_TEXT"><a id="-6270153">dori vositasining xalqaro patentlanmagan nomi, dorining shakli, dozasi, chiqarilish shakli;</a></div><div class="ACT_TEXT"><a id="-6270154">ishlab chiqaruvchi davlatning nomi;</a></div><div class="ACT_TEXT"><a id="-6270155">ishlab chiqaruvchining (ishlab chiquvchining) nomi, uning tashkiliy-huquqiy shakli, davlati;</a></div><div class="ACT_TEXT"><a id="-6270156">dori vositalarining farmakoterapevtik guruhi, ATC (ATX, ATK) (anatomo-terapevtik-kimyoviy) kodi;</a></div><div class="ACT_TEXT"><a id="-6270157">tibbiy buyum va tibbiy texnikaning qoʻllanilish sohasi;</a></div><div class="ACT_TEXT"><a id="-6270158">guvohnoma raqami;</a></div><div class="ACT_TEXT"><a id="-6270159">guvohnoma berilgan sana;</a></div><div class="ACT_TEXT"><a id="-6270160">guvohnomaga oʻzgartirish kiritilgan sana;</a></div><div class="CHANGES_ORIGINS"><label id="s1104"></label><a id="-6270162">(40-band Oʻzbekiston Respublikasi Prezidentining 2022-yil 26-oktabrdagi PQ-411-sonli <a href="/acts/-6252758?ONDATE=27.10.2022 00#-6254233">qarori</a> tahririda — Qonunchilik maʼlumotlari milliy bazasi, 27.10.2022-y., 07/22/411/0961-son)</a></div><div class="ACT_TEXT" style="color:#808080;"><a id="-7404375"></a></div><div class="COMMENT"><label id="s3935"></label><a id="edi-7404375"><a href="/acts/-3594817?ONDATE=15.02.2025 00#edi-7404377">Keyingi</a> tahrirga qarang.</a></div><div class="ACT_TEXT"><a id="-3596353">41. Berilgan guvohnomalar reyestridagi maʼlumotlar yuridik va jismoniy shaxslarning ular bilan tanishishi uchun ochiq hisoblanadi.</a></div><div class="COMMENT"><label id="s3934"></label><a id="edi-6270164"><a href="/acts/-3594817?ONDATE=26.03.2018 00#-3596357">Oldingi</a> tahrirga qarang.</a></div><div class="BY_DEFAULT"><a id="-6270164"></a></div><div class="APPL_BANNER_LANDSCAPE_TITLE"><a id="-6270166">Dori vositalari, tibbiy buyumlar va tibbiy texnikani davlat roʻyxatidan oʻtkazish hamda roʻyxatdan oʻtkazilganlik guvohnomasi berish tartibi toʻgʻrisida<a href="/acts/-3594817#-3596059"> nizomga <br /></a>1-ILOVA </a></div><div class="ACT_TITLE_APPL"><a id="-6270168">Dori vositalari, tibbiy buyumlar va tibbiy texnikani davlat roʻyxatidan oʻtkazish</a></div><div class="ACT_FORM"><a id="-6270169">SXEMASI</a></div><div class="BY_DEFAULT" style="color:#808080;"><a id="-6270170"></a></div><div class="BY_DEFAULT" style="color:#808080;"><a id="-6270172"><table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0">
<tbody>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: windowtext 1pt solid; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="10%" colspan="2">
<p style="LINE-HEIGHT: normal" align="center"><b><span style="FONT-SIZE: 12pt">Bosqichlar</span></b></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: windowtext 1pt solid; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="16%">
<p style="LINE-HEIGHT: normal" align="center"><b><span style="FONT-SIZE: 12pt">Subyektlar</span></b></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: windowtext 1pt solid; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="42%">
<p style="LINE-HEIGHT: normal" align="center"><b><span style="FONT-SIZE: 12pt">Tadbirlar</span></b></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: windowtext 1pt solid; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="18%">
<p style="LINE-HEIGHT: normal" align="center"><b><span style="FONT-SIZE: 12pt">Bajarish muddatlari</span></b></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="5%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="4%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="16%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="42%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="18%">
<p style="LINE-HEIGHT: normal" align="center"></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="10%" colspan="2" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">1-bosqich</span></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="16%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Ariza beruvchi</span></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="42%" rowspan="2">
<p style="TEXT-INDENT: 9.4pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">Dori vositalari, tibbiy buyumlar va tibbiy texnikaning guvohnomasini olish uchun zarur boʻlgan hujjatlarni va namunalarni Davlat markaziga taqdim etadi.</span></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="18%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Ariza beruvchining xohishiga koʻra</span></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="5%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="4%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="16%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="42%">
<p style="TEXT-INDENT: 9.4pt; LINE-HEIGHT: normal"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="18%">
<p style="LINE-HEIGHT: normal" align="center"></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="10%" colspan="2" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">2-bosqich</span></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="16%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Roʻyxatdan oʻtkazish boʻlimi</span></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="42%" rowspan="2">
<p style="TEXT-INDENT: 9.4pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">Roʻyxatdan oʻtkazish, roʻyxatdan oʻtkazish muddatini uzaytirish va birlamchi (dastlabki) ekspertizadan oʻtkazish uchun taqdim etilgan ariza, hujjatlar va namunalarni qabul qiladi.</span></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="18%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">5 kun</span></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="5%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="4%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="16%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="42%">
<p style="TEXT-INDENT: 9.4pt; LINE-HEIGHT: normal"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="18%">
<p style="LINE-HEIGHT: normal" align="center"></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="10%" colspan="2" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">3-bosqich</span></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="16%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Roʻyxatdan oʻtkazish boʻlimi</span></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="42%">
<p style="TEXT-INDENT: 9.4pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">1. Davlat markazi va ariza beruvchi oʻrtasida shartnoma tuzilishini taʼminlaydi va toʻlov varaqasini rasmiylashtiradi.</span></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="18%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">1) Birlamchi (dastlabki) ekspertiza oʻtkazilgandan keyin 1 kun</span></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="42%">
<p style="TEXT-INDENT: 9.4pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">2. Taqdim etilgan hujjatlar va namunalarni tarkibiy boʻlinmalarga hamda tegishli hujjatlar toʻplamini “Zarur amaliyotlar markazi” DUKga yuboradi.</span></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="18%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">2) Ariza beruvchi tomonidan yigʻim summasi toʻlangandan keyin 1 kun</span></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="5%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="4%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="16%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="42%">
<p style="TEXT-INDENT: 9.4pt; LINE-HEIGHT: normal"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="18%">
<p style="LINE-HEIGHT: normal" align="center"></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="10%" colspan="2" rowspan="17">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">4-bosqich</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="16%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Davlat markazi laboratoriyalari</span></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="42%" rowspan="2">
<p style="TEXT-INDENT: 9.4pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">Laboratoriya sinovlarini oʻtkazadi (Jahon sogʻliqni saqlash tashkiloti tomonidan qayta malakalangan dori preparatlari va “in vitro” tashxis tibbiy buyumlari bundan mustasno), Davlat markazining boshqa tarkibiy boʻlinmalariga xulosalar taqdim etadi.</span></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="18%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">1) Sinovlar — 65<a href="/acts/-3594817#-6270183">*</a> kungacha</span></p>
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">2) Amal qilish muddatini uzaytirish va roʻyxatdan oʻtkazish hujjatlariga oʻzgartirishlar kiritish — 30 kungacha</span></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="16%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="42%">
<p style="TEXT-INDENT: 9.4pt; LINE-HEIGHT: normal"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="18%">
<p style="LINE-HEIGHT: normal" align="center"></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="16%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Farmakologiya qoʻmitasi</span></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="42%" rowspan="8">
<p style="TEXT-INDENT: 9.4pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">Taqdim etilgan hujjatlarni ekspertizadan oʻtkazadi, ularni Davlat markazi laboratoriyalarining xulosalari bilan taqqoslaydi. Roʻyxatdan oʻtkazish hujjatlariga oʻzgartirishlar kiritadi.</span></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="18%" rowspan="14">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">65<a href="/acts/-3594817#-6270187">**</a> kungacha</span></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="16%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="16%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Farmakopeya qoʻmitasi</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="16%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="16%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Yangi tibbiy texnika qoʻmitasi</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="16%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="42%">
<p style="TEXT-INDENT: 9.4pt; LINE-HEIGHT: normal"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="16%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Narkotiklar nazorati qoʻmitasi</span></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="42%" rowspan="2">
<p style="TEXT-INDENT: 9.4pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">Taqdim etilgan hujjatlarni ekspertizadan oʻtkazadi (dori vositasining tarkibida giyohvandlik vositalari, psixotrop moddalar va prekursorlar boʻlgan hollarda).</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="16%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="42%">
<p style="TEXT-INDENT: 9.4pt; LINE-HEIGHT: normal"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="16%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">“Zarur amaliyotlar markazi” DUK</span></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="42%" rowspan="2">
<p style="TEXT-INDENT: 9.4pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">Dori vositalari ishlab chiqaruvchi korxonalarning “Zarur ishlab chiqarish amaliyoti (GMP)” standarti talablariga muvofiqligi yuzasidan joyiga chiqqan holda, joyiga chiqishning imkoni boʻlmagan taqdirda masofadan (onlayn) farmatsevtik inspeksiya oʻtkazadi va inspeksiya natijalari boʻyicha Ekspertlar kengashiga xulosa taqdim etadi.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="5%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="4%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="16%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="42%">
<p style="TEXT-INDENT: 9.4pt; LINE-HEIGHT: normal"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="18%">
<p style="LINE-HEIGHT: normal" align="center"></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="10%" colspan="2" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">5-bosqich</span></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="16%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Farmakopeya, Farmakologiya, Yangi tibbiy texnika qoʻmitalari</span></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="42%" rowspan="2">
<p style="TEXT-INDENT: 9.4pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">Dori vositalari, tibbiy buyumlar va tibbiy texnikani tibbiyot amaliyotida qoʻllashga ruxsat berish yoki rad etish toʻgʻrisidagi tavsiyani Ekspertlar kengashi majlisida koʻrib chiqish va muhokama qilishga tayyorlaydi.</span></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="18%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">16<a href="/acts/-3594817#-6270190">***</a> kungacha</span></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="5%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="4%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="16%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="42%">
<p style="TEXT-INDENT: 9.4pt; LINE-HEIGHT: normal"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="18%">
<p style="LINE-HEIGHT: normal" align="center"></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="10%" colspan="2" rowspan="5">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">6-bosqich</span></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="16%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Ekspertlar kengashi</span></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="42%" rowspan="2">
<p style="TEXT-INDENT: 9.4pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">Dori vositalari, tibbiy buyumlar va tibbiy texnikani tibbiyot amaliyotida qoʻllashga ruxsat berish yoki rad etish toʻgʻrisida qaror qabul qiladi.</span></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="18%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">1 kun</span></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="16%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="42%">
<p style="TEXT-INDENT: 9.4pt; LINE-HEIGHT: normal"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="18%">
<p style="LINE-HEIGHT: normal" align="center"></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="16%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Roʻyxatdan oʻtkazish boʻlimi</span></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="42%" rowspan="2">
<p style="TEXT-INDENT: 9.4pt; LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">Guvohnomani rasmiylashtiradi va ariza beruvchiga beradi (yoki yuboradi).</span></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 14.2pt" width="18%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">1 kun</span></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td></tr>
<tr style="HEIGHT: 14.2pt">
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="5%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="4%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="16%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="42%">
<p style="TEXT-INDENT: 9.4pt; LINE-HEIGHT: normal"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="1%">
<p style="LINE-HEIGHT: normal" align="center"></p></td>
<td style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 2.85pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 2.85pt; BACKGROUND: white; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; HEIGHT: 14.2pt" width="18%">
<p style="LINE-HEIGHT: normal" align="center"></p></td></tr></tbody></table></a></div><div class="FOOTNOTE" style="color:#808080;"><a id="-6270182">Izohlar:</a></div><div class="FOOTNOTE" style="color:#808080;"><a id="-6270183">* 40 kungacha — qadoqlangan va oʻrash-joylash materialiga joylangan farmakopeya dorivor oʻsimlik xom ashyosi shaklidagi dori vositalari, bogʻlov materiallari, teshish, inyeksiya, transfuziya va soʻrib olish uchun qoʻllaniladigan buyumlar, kontratseptivlar, rezina, rezina mato, lateks, polimerdan tayyorlangan tibbiy buyumlar, birinchi tibbiy yordam koʻrsatish, bemorlarni parvarish qilish uchun tibbiy buyumlar;</a></div><div class="FOOTNOTE" style="color:#808080;"><a id="-6270185">20 kungacha — substansiyalarni roʻyxatdan oʻtkazish uchun;</a></div><div class="FOOTNOTE" style="color:#808080;"><a id="-6270187">** 40 kungacha — qadoqlangan va oʻrash-joylash materialiga joylangan farmakopeya dorivor oʻsimlik xom ashyosi shaklidagi dori vositalari, bogʻlov materiallari, teshish, inyeksiya, transfuziya va soʻrib olishga moʻljallangan buyumlar, kontratseptivlar, rezina, rezina mato, lateks, polimerdan tayyorlangan tibbiy buyumlar, birinchi tibbiy yordam koʻrsatish, bemorlarni parvarish qilish uchun tibbiy buyumlar;</a></div><div class="FOOTNOTE" style="color:#808080;"><a id="-6270188">36 kungacha — Jahon sogʻliqni saqlash tashkiloti tomonidan qayta malakalangan dori preparatlari va “in vitro” tashxis tibbiy buyumlarini roʻyxatdan oʻtkazish uchun;</a></div><div class="FOOTNOTE" style="color:#808080;"><a id="-6270189">14 kungacha — substansiyalarni roʻyxatdan oʻtkazish uchun;</a></div><div class="FOOTNOTE" style="color:#808080;"><a id="-6270190">*** 7 kungacha — substansiyalarni roʻyxatdan oʻtkazish uchun.</a></div><div class="FOOTNOTE" style="color:#808080;"><a id="-6270191">Roʻyxatdan oʻtkazish uchun umumiy belgilangan 155 kundan oshmaydigan muddatga quyidagilar kiritilmaydi:</a></div><div class="FOOTNOTE" style="color:#808080;"><a id="-6270192">dori vositalari, tibbiy buyumlar va tibbiy texnikani ekspertizadan oʻtkazish jarayonida aniqlangan kamchiliklarni bartaraf etish va tegishli hujjatlarni taqdim etish uchun belgilangan 45 kundan oshmaydigan muddat;</a></div><div class="FOOTNOTE" style="color:#808080;"><a id="-6270193">klinik sinovlar oʻtkazish uchun klinik bazalarga ariza beruvchi tomonidan tegishli tartibda kelishilgan klinik sinovlar dasturlarini, dori vositalari, tibbiy buyumlar va tibbiy texnika namunalarini taqdim etish uchun belgilangan 45 kundan oshmaydigan muddat;</a></div><div class="FOOTNOTE" style="color:#808080;"><a id="-6270195">jenerik dori vositalarining klinik tadqiqotlarini oʻtkazishning bevosita bir yildan oshmaydigan, original dori vositalarining klinik tadqiqotlarini oʻtkazishning uch yildan oshmaydigan muddatlari.</a></div><div class="FOOTNOTE" style="color:#808080;"><a id="-6270198">Dori moddalari (substansiyalar)ni va Jahon sogʻliqni saqlash tashkiloti tomonidan qayta malakalangan dori preparatlarini roʻyxatdan oʻtkazishda klinik tadqiqotlar oʻtkazilmaydi.</a></div><div class="CHANGES_ORIGINS" style="color:#808080;"><label id="s1104"></label><a id="-6270204">(1-ilova matni Oʻzbekiston Respublikasi Prezidentining 2022-yil 26-oktabrdagi PQ-411-sonli <a href="/acts/-6252758?ONDATE=27.10.2022 00#-6254246">qarori</a> tahririda — Qonunchilik maʼlumotlari milliy bazasi, 27.10.2022-y., 07/22/411/0961-son)</a></div><div class="COMMENT"><label id="s3935"></label><a id="edi-6270204"><a href="/acts/-3594817?ONDATE=15.02.2025 00#edi-7404393">Keyingi</a> tahrirga qarang.</a></div><br /><div class="PUBLICATION_ORIGIN"><label id="s1089"></label><a id="-3595995">(Qonun hujjatlari maʼlumotlari milliy bazasi, 26.03.2018-y., 09/18/213/09038-son; 11.08.2019-y., 09/19/661/3571-son, 17.08.2019-y., 09/19/678/3577-son, 29.12.2019-y., 09/19/1046/4242-son; Qonunchilik maʼlumotlari milliy bazasi, 06.05.2021-y., 06/21/6221/0428-son, 03.08.2021-y., 09/21/486/0748-son, 29.10.2021-y., 09/21/661/0999-son, 29.12.2021-y., 09/21/786/1216-son; 05.04.2022-y., 09/22/153/0266-son, 26.04.2022-y., 07/22/221/0357-son, 21.09.2022-y., 09/22/519/0840-son, 27.10.2022-y., 07/22/411/0961-son; 21.01.2023-y., 07/23/12/0041; 04.09.2024-y., 09/24/535/0679-son; 15.02.2025-y., 09/25/67/0145-son)</a></div></div>
                
            </div>
        </section>
        
    </div>
    
    <div style="display: none;">
<!-- START WWW.UZ TOP-RATING -->
<SCRIPT language="javascript" type="text/javascript">
		<!--
		top_js = "1.0"; top_r = "id=4079&r=" + escape(document.referrer) + "&pg=" + escape(window.location.href); document.cookie = "smart_top=1; path=/"; top_r += "&c=" + (document.cookie ? "Y" : "N")
		//-->
</SCRIPT>
<SCRIPT language="javascript1.1" type="text/javascript">
<!--
		top_js = "1.1"; top_r += "&j=" + (navigator.javaEnabled() ? "Y" : "N")
//-->
</SCRIPT>
<SCRIPT language="javascript1.2" type="text/javascript">
<!--
		top_js = "1.2"; top_r += "&wh=" + screen.width + 'x' + screen.height + "&px=" + (((navigator.appName.substring(0, 3) == "Mic")) ? screen.colorDepth : screen.pixelDepth)
//-->
</SCRIPT>
<SCRIPT language="javascript1.3" type="text/javascript">
<!--
		top_js = "1.3";
//-->
</SCRIPT>
<SCRIPT language="JavaScript" type="text/javascript">
		<!--
		top_rat = "&col=0C57A6&t=ffffff&p=DD7900"; top_r += "&js=" + top_js + ""; document.write('<a href="https://www.uz/rus/toprating/cmd/stat/id/4079" target="_blank"><img src="https://www.uz/plugins/top_rating/count/cnt.png?' + top_r + top_rat + '" width=88 height=31 border=0 alt="Топ рейтинг www.uz"></a>')//-->
</SCRIPT>
<NOSCRIPT>
		<A href="https://www.uz/rus/toprating/cmd/stat/id/4079" target="_blank">
				<img height="31" src="https://www.uz/plugins/top_rating/count/nojs_cnt.png?id=4079&pg=http%3A//lex.uz&col=0C57A6&t=ffffff&p=DD7900" width="88" border="0" alt="Топ рейтинг www.uz">
		</A>
</NOSCRIPT>
<!-- FINISH WWW.UZ TOP-RATING --></div>
</body>
</html>
<script> 
    function scrollText(hash) {
        location.href = "#" + hash;
        //$('html,body').animate({
        //    scrollTop: $(window).scrollTop() - 75
        //});
    }
</script>
<script>     
    //function scrollToElement(selector, time, verticalOffset) {
    //    time = typeof (time) != 'undefined' ? time : 1000;
    //    verticalOffset = typeof (verticalOffset) != 'undefined' ? verticalOffset : 0;
    //    element = $(selector);
    //    offset = element.offset();
    //    offsetTop = offset.top + verticalOffset;
    //    $('html, body').animate({
    //        scrollTop: offsetTop
    //    }, time);
    //}

    //jQuery.fn.extend({
    //    scrollToMe: function () {
    //        var x = jQuery(this).offset().top - 100;
    //        jQuery('html,body').animate({ scrollTop: x }, 500);
    //    }
    //});

    //function opentInAct(id) {
    //    $("#" + id).scrollToMe();
    //}

    $(document).ready(function () {
        $("#theDefCssID TABLE TD").css('display', '');
    });
</script>
<style>
    #divCont > DIV {
        margin-left: -2px;
        margin-right: -2px;
        padding-left: 2px;
        padding-right: 2px;
    }

    TD.fTD {
        width: 22px;
    }

    .OFFICIAL_SOUR_TEXT {
        display: none;
    }

    /*.document_view_body*/ header {
        clear: both;
        float: left;
        height: 36px;
        width: 100%;
        background-color: #2263a9;
    }

        /*.document_view_body header .logo {
            float: left;
            padding: 0 12px;
        }*/

        /*.document_view_body header nav.main_menu {
            float: none;
        }*/

        /*nav.main_menu {
        float: left;
        padding-left: 22px;
        position: relative;
        z-index: 9;
    }*/

        /*nav.main_menu > div {
            float: left;
            height: 34px;
            margin-top: 1px;
            width: 21px;
        }*/

        /*.document_view_body header nav.main_menu > ul {
        float: none;
        font-family: helvatica;
        font-size: 11px;
    }*/

        /*nav.main_menu > ul {
        float: left;
        font-size: 16px;
    }*/

        /*nav ul, nav ol {
        list-style: none outside none;
        margin: 0;
        padding: 0;
    }*/

        /*ul, ol {
        margin: 1em 0;
        padding: 0 0 0 40px;
    }*/


        /*.document_view_body header .logo a {
        display: block;
        width: 100%;
    }*/


        /*.document_view_body*/ header .logo a span {
            background: url("/images/bg/doc_v_logo.png") no-repeat scroll center center transparent;
            display: block;
            height: 36px;
            width: 85px;
        }

    /*.hover-popup {
        display: none;
        border: 1px solid #969696;
        border-radius: 5px;
        -moz-border-radius: 5px;
        -webkit-border-radius: 5px;
        -o-border-radius: 5px;
        -ms-border-radius: 5px;
        position: absolute;
        behavior: url(css/PIE.htc);
        box-shadow: 2px 2px 6px -2px #555;
        padding: 7px;
        background: #fdffde;
        bottom: 28px;
        left: 10px;
        max-width: 500px;
        text-overflow: ellipsis;
        white-space: nowrap;
        color: #000;
        overflow: hidden;
    }*/

    /*.pre-loader {
        text-align: center;
        width: 100%;
        padding-bottom: 0 !important;
    }*/

    /*.actondate {
        width: 385px;
        height: 46px;
        background-color: White;
        z-index: 2000;
        font-family: Arial;
        font-size: 14px;
        font-weight: bold;
        opacity: 0.7;
        padding-top: 10px;
        text-align: center;
        top: 37px;
    }*/
</style>
